US20110202085A1 - Braid Ball Embolic Device Features - Google Patents
Braid Ball Embolic Device Features Download PDFInfo
- Publication number
- US20110202085A1 US20110202085A1 US12/942,217 US94221710A US2011202085A1 US 20110202085 A1 US20110202085 A1 US 20110202085A1 US 94221710 A US94221710 A US 94221710A US 2011202085 A1 US2011202085 A1 US 2011202085A1
- Authority
- US
- United States
- Prior art keywords
- implant
- braid
- sleeve
- proximal
- marker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
Definitions
- Braid-ball devices formed with folded-over and folded-flat distal end are among the architectures described in Becking, et al. These architectures are the ones best suited for treating brain aneurysms. Distal marker approaches are described that are especially suited for such devices. In addition, proximal end finishing approaches are described that are suitable for these and the rest of the devices described in Becking et al. All of the features and technologies presented in Becking, et al. (U.S. patent application Ser. No. 12/465,475 and PCT/US2009/041313) are incorporated herein by reference.
- one improvement comprises a tether to/for the distal marker included in the implant.
- the length of the tether/tie extends to the proximal hub of the implant. It has a length set so that when the implant is compressed, the marker is pulled into alignment with the implant and/or catheter.
- a suture When a suture is employed for the tether, it can tie around the interior of the distal fold with minimal interference. However, it may be advantageous to use a wire ribbon (e.g., Pt or Nitinol) for other reasons.
- a wire ribbon e.g., Pt or Nitinol
- a tether ribbon (especially when pre-formed into a “V” shape) can be threaded through the gap/hole and around as few as one wire from the braid. So-disposed, there is no interference with the compression of the distal end of the implant. What is more, spring action in the ribbon tether (whether comprising two filaments or trimmed to one after crimping, gluing, welding or otherwise affixing at least one marker) can help position the marker against/across the top of the implant when deployed. Such a ribbon can also contribute to marker radiopacity, thereby allowing a smaller marker size.
- proximal end of the tether is advantageously captured between the layers of braid or between the braid and either one of optional inner or outer bands. It may be glued-in, affixed by welding or otherwise.
- Yet another set of improvements concerns the manner in which the implant is finished.
- finished what is meant is the manner in which the proximal side of the implant is managed to define a hub and/or delivery system detachment interface.
- an inner band in which use of an inner band is desired for interface with detachment system components (such as those described in the referenced application), processing is done with an elongate hypotube set within the braid.
- the hypotube e.g., about 2-5 cm long
- the remaining portion of the hypotube within the implant (now the “inner band”) defines the detachment interface lumen.
- the same structure will improve and/or offer the requisite radiopacity at the proximal end of the implant.
- the approach (optionally characterized as a “sacrificial hypotube length” approach) is useful for gluing but may also be applied in a welding technique.
- it may be especially useful in the latter context by providing shielding from weld slag and deformation for the proximal aperture/port to be exposed by trimming the tube to define the inner band in the implant.
- a clean cut can be made (e.g., with a diamond saw, laser cutting, EDM, etc.—as above) and then any deburring (by mechanical action, etching, EP or otherwise) can be performed on the newly-exposed face as desired.
- an outer band is used at the proximal end of the implant to define an outer casting boundary for adhesive/glue (e.g., Loctite 4014), it then may be removed leaving the underlying glue casting in place.
- Outer band removal offers potential to reduce all of the height, diameter and appearance of the size of the proximal feature of the implant. Accordingly, it may assist in developing a system with 0.021′′ catheter crossing profile.
- the band may advantageously comprise NiTi alloy (that naturally forms a passivation layer) or it may be coated or otherwise plated.
- a Titanium Nitride coating may be desirable.
- Spray mold release e.g., 3M
- dip-coating in mold release may alternatively be employed to assist in slipping-off the band after adhesive application and curing. Otherwise, the band can be cut off the glue casting.
- the proximal/lower NiTi section can be easily welded to the NiTi braid in the ball (when so-constructed) and the Pt (including Pt/Ir and other alloys) provides an in-line radiopaque marker.
- the detachment system control and anchor wires are received through both bands.
- the bands may be attached (e.g., by welding, gluing or soldering) or merely associated with each other until detachment system wire removal. In either case, they may include interference fit, puzzle-piece or other groove or tongue-and-groove features to make or assist in making a connection between the bodies.
- Another set of improvements concerns shaping the distal end of a “folded-flat” type implant. It may be provided with a flattened top.
- the flattened top derives from a flat formed in the round tooling over which the braid is shaped.
- the flat can be produced by milling about 0.010′′ off the form. This depth cut allows sufficient “table” for desired shaping and can be consistently applied across a range of implants sized from about 5 mm to 12 mm in diameter with little effect on the perceived shape.
- the resulting crease in the implant wire shaped by such a form offers an immediate advantage to implant deployment.
- shape recovery of the bend/crease around the flattened top drives early opening of the implant when unsheathed (as compared to a situation where a crease formed around the flat is set further away—or none is provided).
- Yet another set of implant improvements described herein augments the density of the ball. Stated otherwise, provision is made for an additional layer of braid material to further decrease the braid matrix porosity, and possibly do so without any increase in device crossing profile/delivery (micro)catheter compatibility.
- a third layer of braid that is added to the two layers preferably already present in the folded-flat base implant architecture.
- a third layer of braid is captured between the two layers and captured within the hub region, but trimmed proximal to the distal folded-over/flat section.
- an inner layer is set within the envelope of the aforementioned two layers. It is advantageously attached to a distal end of the inner marker band (above/distal) to any outer marker band provided. As such, the braid's attachment will not increase the hub profile. To avoid any profile increase at the distal end of the implant, the inner layer will typically be trimmed so its compressed length is located proximal to the folded-over braid at the distal end of the implant when compressed.
- the inner layer may simply define a cup. Alternatively, it may define a secondary ball shape. Such a ball shape may be substantially spherical or ovoid.
- One advantageous configuration further includes unterminated distal ends to the braid. The ends of the braid defining the inner ball may be secured in a band or welded together. So-configured they can offer another radiopaque marker feature within the ball. However, it may be preferred that the braid ends of the inner layer (in cup, ball form, or otherwise) are unterminated. As such, they may improve thrombus formation within the body of the implant.
- FIGS. 1A and 1B show an implant with a marker tether as expanded and being compressed, respectively;
- FIGS. 2A and 2B show the distal end and a side view of another tethered-marker embodiment, respectively;
- FIG. 3 is a detail view of a marker/tether subassembly
- FIG. 4 diagrammatically illustrates the assembly in FIG. 3 set within an implant
- FIG. 5 shows an implant preform prepared for proximal end finishing
- FIG. 6 shows the proximal end welded
- FIG. 7 shows an implant preform prepared for proximal end finishing according to another approach
- FIG. 8 shows the proximal end cut and welded
- FIGS. 9A and 9B show implants employing alternative proximal end finishing approaches, with a detail view in FIG. 9B of a low-profile embodiment
- FIGS. 10A and 10B show additional proximal end radiopaque features as may be employed with various end-finishing approaches;
- FIG. 11 shows in implant formed with a distal flattened top
- FIG. 12 shows implant forms for imparting an implant shape as shown in FIG. 11 across a number of different implants of a given size range
- FIGS. 13A and 13B respectively, illustrate the operation of an implant shaped according to FIG. 11 / 12 as compared to one that is not;
- FIGS. 14-17 diagrammatically illustrate improved density implants as compared to the architecture presented in FIG. 4 ;
- FIG. 18 shows an overview of an implant/detachment system interface as may be employed in connection with the present invention
- FIGS. 19A-19E and 20 A- 20 E illustrate the stages of operation (handle-side and implant-side, respectively) of the system shown in FIG. 18 ;
- FIG. 21 shows an optional improvement to the architecture of the same system
- FIGS. 22A and 22B show an alternative delivery system interface engaged and disengaged, respectively
- FIG. 23 is an end-on view of the delivery system interface as pictured in FIG. 22B .
- FIGS. 24A and 24B illustrate alternative end-on views of the configuration of a pusher shaft in the same system
- FIGS. 25A and 25B show alternative delivery system interface options (engaged and disengaged, respectively) based on the pusher shaft configuration in FIG. 24B ;
- FIG. 26 shows an alternative implant-side interface with a delivery system as presented in FIGS. 25A and 25B ;
- FIG. 27 shows an implant-side interface like that presented in FIG. 26 with an alternative pusher-side architecture
- FIGS. 28A and 28B show an alternative engagement/disengagement interface for a system like that shown in FIGS. 22A and 22B ;
- FIGS. 29 and 30 show yet another engagement/disengagement architecture for each of a braid-type implant and embolic coil, respectively.
- FIGS. 1A and 1B show an implant 10 .
- implant 10 includes a tie 22 positioned between braid layers 12 and 14 adjacent a distal fold 16 in the braid, which defines aperture 18 (also referred to herein as the hole or gap in the braid). Marker 20 is held by tie 22 . Tie 22 may also assist in closing or limiting the size to which aperture 18 may open.
- tie 22 terminates adjacent marker 20 in Becking et al., it extends to proximal hub 30 of implant 10 in the present description.
- the extension “tether” portions, or members, 24 so-provided operate to ensure axial alignment of marker 20 when implant 10 is captured (especially when re-capturing) in a catheter/sheath.
- the length of tether member(s) 24 is therefore set such that slack is present when the implant is expanded (as shown in FIG. 1A ) and the slack is removed when the implant is fully compressed or tending thereto (as shown in FIG. 1B ).
- the tie and/or tether member shown in FIGS. 1A and 1B is typically made of suture material, it may be made of any other biocompatible material including stainless steel, titanium, Nitinol (possibly wire that is martinistic at body temperature—commonly referred to as “muscle wire”), and the like.
- suture material When suture material is employed it can tie around the interior of distal fold 16 with minimal interference and be knotted at point 26 (see FIG. 1A ) to easily secure the position of marker 20 .
- the same approach may be accomplished with fine wire (e.g., 0.001 inch round wire.)
- wire ribbon e.g., Pt or Nitinol
- wire ribbon e.g., Pt or Nitinol
- a tether ribbon 22 heatset into a tight loop or “V” shape was threaded through gap 20 and around as few as one wire from the braid at a distal end of implant 10 as shown in FIG. 4 . So-disposed, tether ribbon 22 does not substantially interfere with compression of the distal end of the implant. What is more, spring action in the tether ribbon (whether comprising two filaments or trimmed to just one filament (as indicated by the broken line) after crimping, gluing, welding or otherwise affixing marker 20 as shown in FIG. 3 ) can help position marker 20 against (or across) the top of implant 10 when deployed, as shown in FIGS. 2A and 2B . As for affixing the marker, it is notable that the paired ribbon sections, stacked upon each other, provide a good interface upon which to crimp marker 20 without drastically altering the marker's shape.
- the length of the tether may optionally be set in a general “question-mark” shape to match (or more closely match) the curvature of the implant when unconstrained (e.g., as the tether appears in FIG. 4 ). Pre-shaping the tether to “match” (or approximately match) one or more implant sizes can help ensure predictable and similar performance of implants across a range of different implant sizes and compressions.
- FIG. 5 shows an implant preform 60 prepared for proximal end finishing.
- implant preform 60 such as prepared in Becking, et al. is prepared, leaving an additional overhang section 50 extending past a proximal marker band 32 .
- the setup resembles that shown in FIG. 13A of Becking et al. with the implant preform 60 including an inner NiTi tube 34 and the assembly set upon a mandrel 52 .
- glue e.g., Loctite 4014
- the hub region 30 can be welded effectively with a weld bead 54 incorporating the overhanging braid 50 , inner tube 34 and at least tack-welding an outer Pt band 32 .
- a weld bead 54 incorporating the overhanging braid 50 , inner tube 34 and at least tack-welding an outer Pt band 32 .
- the length of the braid overhang incorporated into weld 54 may vary depending on a number of factors including implant diameter, wire diameter, braid density, etc. As shown, the overhang is about 0.005 to about 0.010 inches in length.
- preform 62 is not trimmed and stabilized for welding as shown in FIG. 5 . Rather, preform 62 is prepared upon an elongate hypotube 54 .
- the hypotube body provides a means to hold the construct and stabilize its elongate “tail” section 56 of braid layer 12 and/or layer 14 (e.g., by a wrap 58 ) thereon.
- laser energy is applied as indicated by the larger area.
- the energy is sufficient to weld the braid to the hypotube.
- the welding process does not, however, weld the hypotube to the optional underlying mandrel 52 .
- hypotube 54 After such welding, the majority of the length of hypotube 54 is “sacrificed”. It is trimmed-off to define the inner band 34 of the implant as shown in FIG. 8 .
- This inner band may provide some or all of the radiopacity required in the hub region 30 .
- an outer band (especially if it comprises Pt) can be tack welded to the braid as indicated by the arrow Z in FIG. 7 .
- FIG. 8 illustrates an advantage of the finishing approach, namely, the avoidance of weld bead flow artifacts associated with surface tension at the end of a body (as seen in FIG. 6 ). Rather, the weld 64 is neatly faced and the inner lumen of the remaining band 34 de-burred and/or reamed. Both actual and apparent hub size can be minimized accordingly.
- FIGS. 9A and 9B illustrate another advantageous proximal end finishing approach for minimizing proximal hub size.
- FIG. 9A shows an implant with an outer marker band 32 as it will generally appear as affixed by glue or welding. In instances where such a band is affixed by glue, once a glue cast is formed therein the band can be removed.
- An implant 10 ′ will then include a proximal hub 30 ′ that is reduced in diameter (by as much as about 0.004 inches depending on band thickness) and is also less noticeable by offering less contrast. Outside the body (e.g., in packaging) a physician will see a glaze or sheen of adhesive/glue 70 as a cast 72 in which the braid is embedded instead of a high contrast marker 32 .
- FIGS. 10A and 10B illustrate additional embodiments that eliminate the outer band while providing relatively increased radiopacity.
- minimal implant hub size can be achieved by relocating a radiopaque band feature to an in-line arrangement with the inner band 34 .
- a simple Pt band 74 can be set atop the inner band 34 as shown in FIG. 10A .
- These members may be joined using conventional techniques (i.e., gluing, soldering, welding, etc.) or be held in relation to one another on a temporary basis by utilizing delivery system interface members as shown in FIG. 18 , etc. to the embodiment of FIG. 10B interlocks members 34 and 74 through the use of lock 76 and key 78 features.
- the implant optionally includes a flattened top 80 adjacent distal aperture 18 .
- the flattened top is generated by providing a table surface 82 in the molding element 88 used to define the bulk shape of the implant. Molding elements, or “forms,” in different sizes 88 , 88 ′ and 88 ′′ are shown in FIG. 12 . They are milled down from a spherical form to define flat 82 surrounded by edge 84 . The edge produces a crease 86 in the braid wire. Note that flat 80 and crease 86 are shown in alternate views in FIGS. 2A and 2B .
- the flat section improves the quality of the distal fold 16 in the implant, helping to maximize uniformity and minimize the bend radius in the wires. As such, device trackability through tortuous anatomy within a catheter is also improved.
- the crease at the edge of the flattened area set in the implant also helps with delivery performance upon deployment. Specifically, as illustrated in FIG. 13A , the crease 86 represents multiple bends in the wires forming the implant braid matrix. Upon exit from the microcatheter, the bends recover and cause the implant distal end to open more than an implant without such a crease as shown in FIG. 13B (see also, the implant in FIG. 1B ). As a more open body, the implant is softer, with more relaxed braid angle should it contact any fragile tissue—such as the dome of an aneurysm.
- FIGS. 14-17 Other architectural changes or augmentations that may be applied to implants are shown in FIGS. 14-17 . Each approach offers the potential for diagrammatically improved density relative to the parent architecture illustrated in FIG. 4 .
- implant 90 includes an intermediate braid layer 92 set between outer layer 12 and inner layer 14 .
- Layer 92 is captured in hub 30 as are the other layers at a proximal attachment 94 .
- the distal extent 96 can be set at a number of positions. Advantageously, it extends to around the half-way point or equator of the device. This way, the layer will contribute to implant density (or—stated otherwise—reduce porosity) even for wide-neck aneurysms.
- the distal extent 96 of the braid is adjacent to the folded-over section 16 of the implant.
- the density is highest so the inner layer wires will tend to stay best trapped between layers 12 and 14 .
- the ends 96 do not interfere with the fold 16 (which can be the highest profile aspect of the implant) little or no increase in crossing profile need result.
- the inner layer 92 of the implant can be produced simply by cutting a preform (like preform 62 ) in half at the distal fold. This produces a set of two inner layer sections that can be used in two different devices from a single formation procedure.
- the inner layer may rely on the other layers for structural definition, it may be made of finer wire and/or with lower braid count than the other layers.
- the inner layer may comprise 72-end 0.0008 inch wire braid, whereas the outer layers comprise 96-end 0.0008 inch wire braid.
- the reverse may be true, in which the inner layer is more robust. In any case, it may be advantageous to mismatch the number of wire ends included in the braid (such as in the example directly above) to help avoid wire match-up, thereby minimizing porosity.
- Implant 100 shown in FIG. 15 illustrates another advantageous approach to improving flow disruption effect, without increasing device crossing profile.
- an intermediate braid layer 90 is employed. However its proximal end is not secured within the hub, thereby easing space constraints in that region.
- braid matrix integrity is maintained by coating the braid layer with a polymer (e.g., TICOPHILIC coating by Lubrizol, Inc.) or other coatings or processing.
- Hydrogel coating also offers an appealing option, such as a hydrogel-based polymer network capable of entrapping therapeutic agents as described in U.S. Pat. No. 6,905,700 to Won et al.
- the braid used for any of the layers may instead comprise polymer—especially high strength biodegradable polymer such as MX-2 (MAX-Prene), synthetic absorbable monofilament (90/10 Glycolide/L-Lactide) and/or G-2 (Glycoprene), synthetic absorbable monofilament (Glycolide (PGA), ⁇ -Caprolactone (PCL), Trimethylene Carbonate (TMC) Copolymer) that is heat set into shape (e.g., at 110 degrees centigrade for an hour) and/or coated with the same to stabilize the braid matrix as described.
- MX-2 MAX-Prene
- synthetic absorbable monofilament 90/10 Glycolide/L-Lactide
- G-2 Glycoprene
- Glycolide PGA
- PCL ⁇ -Caprolactone
- TMC Trimethylene Carbonate
- Implant 110 shown in FIG. 16 offers another yet another approach for improved embolizing (or flow disrupting) effect with little or no effect on crossing profile. Such effect is accomplished by affixing an innermost/third braid layer 112 to inner band 34 at its proximal end 114 . It may be welded, glued, soldered or otherwise affixed thereto. The distal end of the braid 116 may be trimmed and formed as shown or otherwise. For example, the cup so-formed may closely follow the inner periphery of the device up to or past its equator.
- the third layer incorporated in the implant simply deploys and recaptures in unison with the rest of the implant.
- the proximal end 114 of the braid is stably secured, but secured such that it does not require space in the hub (e.g., within the outer marker band 32 ) without dimensional stackup.
- FIG. 17 A related implant configuration is shown in FIG. 17 .
- implant 120 the same proximal end 114 attachment approach is employed.
- an inner ball 118 is formed instead of forming (e.g., by heatsetting) the inner layer of braid into a cup shape.
- the proximal side of the ball improves overall proximal-side implant density, and also defines separated flow stagnation zones A and B within the implant to further assist in thrombus formation within the implant.
- Inner ball body 118 may be shape set over a form.
- the shape can be formed without either an external or internal form by bunching the braid up and tying it onto a mandrel for heatsetting.
- Such a “free-forming” approach is functionally advantageous because it maximizes braid angle (hence, density) in the final body.
- any resulting inconsistency in shape is manageable given that the only outer body of the implant defined by braid layers 12 and 14 is in contact with an aneurysm.
- the inner ball 118 within the architecture will be configured so that it will not interfere with the distal end of the implant body/shell and/or marker and tether when the device is compressed for delivery or recapture.
- FIG. 18 provides an overview of implant-side of a treatment system 200 .
- the system includes an implant 10 ( 90 , 100 , 110 , 120 ) and a pusher/catheter shaft 210 ultimately attached to a handle 220 (e.g., as shown in FIGS. 19A-19-E ). Any of these may be constructed according to the teachings herein and/or incorporated by reference.
- One handle construction includes a single plunger.
- the plunger pulls a collar that progressively engages and pulls sockets connected to the wires; first each control wire 212 is pulled (one at a time), then the anchor wire 214 .
- FIGS. 19A-19E and 20 A- 20 E show the device components as removed from packaging.
- FIG. 19B illustrates unlocking the handle plunger 222 with a 120 degree rotation relative to handle body 224 .
- Such action has no effect on the detachment interface 216 shown in FIG. 20B .
- progressive pull of the plunger in FIGS. 19C-19E effect the release of the system as shown in FIGS. 20C-20E .
- FIG. 21 shows an optional improvement to the architecture of system 200 .
- system 200 ′ has only one “true” control wire 212 is received within the hub or inner band 30 / 34 of the implant 10 . Even so, the implant remains securely/stably attached to the catheter shaft by virtue of the control wire interaction with anchor ball 216 (e.g., as formed by laser or as otherwise configured).
- Release of the implant is effected as if progressing from the steps in FIGS. 19C and 20C to 19 E and 20 E.
- a third (floating or actuated) “dummy” wire 218 is still loaded within the lumen of pusher shaft 210 .
- Use of this wire maintains a close-packed arrangement of the wires inside shaft 210 , which can be important in determining wire position within a tortuous setting.
- release angle may be increased and plunger pull force reduced because the wires within the implant have more space between them allowing for spatial accommodation.
- the length “L” by which wire 218 is inset within the pusher shaft may vary depending on purpose. It may have no inset (i.e., essentially abut the implant proximal end). It may be inset by about 1 mm so that any forward motion in a tortuous setting does not result in contact with the implant. Or it may be inset to a greater degree (e.g., between about 1 cm and 5 cm) to improve distal tip flexibility of delivery pusher shaft 210 .
- FIGS. 22A and 22B show an alternative delivery system interface in engaged and disengaged states, respectively.
- system 230 comprises a catheter/pusher shaft 232 actuated with the assistance of a typical torque 234 .
- Torquer 234 locks a position of a central wire 236 including an anchor ball for implant 10 delivery.
- a bumper or shoulder 240 may be affixed to the catheter (optionally a Pt band also serving as a marker) to abut a hub 30 of the implant for pushing.
- extension 242 that is offset into an interfering relationship with an inner band 34 of the implant when the anchor ball 238 is in a retracted position as shown in FIG. 22A .
- extension section 242 is free to move (e.g., to return to its original position by elastic action or upon catheter shaft withdrawal) and slide out of the implant.
- FIG. 23 is an end-on view of the delivery system interface as pictured in FIG. 22B .
- FIG. 24A portrays a similar view without the wire in place. It shows extension 242 and catheter body 232 . And while they are illustrated as formed in one manner (i.e., with a 90 degree cut-down), it is to be appreciated that the extension may instead be formed by an angular cut or otherwise.
- FIG. 24B shows an approach in which the extension section is formed by pushing over the catheter wall on one side to meet the other and optionally heat setting, fusing or gluing the component parts 242 and 242 ′ together.
- FIGS. 25A and 25B show an alternative delivery system interface 250 option (engaged and disengaged, respectively) based on the pusher shaft extension configuration in FIG. 24B . Due to the increased wall thickness offered by the double wall layer, the system can work much as that shown in FIGS. 22A and 22B , except without need for a distal interference feature (i.e., anchor ball/band). As such, withdrawal of wire 236 will relieve the interference and unlock the pusher shaft 232 (specifically, the associated extension) for withdrawal from the implant 10 .
- a distal interference feature i.e., anchor ball/band
- FIG. 26 shows an alternative implant-side interface with a delivery system as presented in FIGS. 25A and 25B .
- an implant socket 260 is provided.
- Socket 260 may be defined by a cup 262 attached to one or more implant braid layers ( 12 / 14 ), by welding or otherwise, and a reducer tube 264 threaded, pressed or otherwise affixed in the proximal end of the cup. Note that with such an arrangement that implant pushing can be accomplished without a shoulder or other proximal interface. Instead, both push and pull (for withdrawal) force application can occur within the socket chamber. While such a socket will typically be larger than the previous interfaces shown, it is easily retrofit or used as and alternative to the screw-type release approaches employed in many vessel sacrifice and closure devices as sold by AGA Medical, Inc. and others.
- FIG. 27 shows the same implant-side interface 260 , with an alternative pusher-side engagement/disengagement (or latch) architecture 270 .
- This architecture is a simplified version of that shown in FIG. 18 of Becking et al.
- a pusher shaft 272 e.g., metal hypotube
- the window (configured as a square cutout, rounded, or a simple kerf) allowing a core member 276 (e.g., NiTi ribbon) to pass therethrough and provide interference against pusher shaft distal face 276 to prevent delivery system detachment until core member withdrawal.
- a core member 276 e.g., NiTi ribbon
- FIGS. 28A and 28B show an alternative latch interface 280 for a system like that shown in FIGS. 22A and 22B .
- a bent back wire hook 282 serves the function of the ball in the former system.
- FIG. 29 shows a system 290 most closely related to that in FIG. 21 , except that multiple control and/or dummy wires are replaced with a single ribbon 292 .
- FIG. 30 shows a detachment system 300 .
- a ribbon 292 may be used in conjunction with a round anchor wire 214 with a ball-shaped anchor 216 .
- An alternative approach that may be used in either system is to employ a ribbon as the “anchor wire” and form the interference feature at its end by tying a knot therein (as a substitute for a laser-formed ball).
- Such a knot can be shape set, glued or welded to stabilize its shape. It can be reliably be produced at low cost at a very small size, on a ribbon.
- a socket-type interface can be formed within the coil by fitting a collar feature 302 within its proximal end.
- the collar may be threaded-in (i.e., into the coils like a thread pitch).
- An alternative approach involves flowing solder between the coils and defining a lumen therein using a removable mandrel.
- the mandrel may be prepared in any manner to facilitate its removal, including those described for the removable hub in connection with the improvement described in connection with FIG. 9B .
- the catheter/pusher shaft comprise a simple extrusion (e.g., PTFE, FEP, PEEK, etc.) or may be constructed using conventional catheter construction techniques and include a liner, braid support and outer jacket (not shown).
- An exemplary construction is available through MicroLumen, Inc. as Braid Reinforced Polyimide.
- a distal section of the Polyimide may be ablated and replaced with fused Pebax to provide a softer or progressively-flexible end to the catheter.
- a loading sheath is typically provided over the pusher shaft.
- the loading sheath is splittable.
- the implant is pulled into the loading sheath.
- the loading sheath is received within the hub of the catheter to be used for implant delivery and the implant is advanced into the catheter. Then, the implant may be advanced to and deployed at a treatment site. Or it may be retrieved in exchange for another size implant—else repositioned, if desired, prior to ultimate detachment as illustrated in the incorporated patent application subject matter.
- the subject methods may include each of the physician activities associated with implant positioning and release.
- methodology implicit to the positioning and deployment of an implant device forms part of the invention.
- Such methodology may include placing an implant within a brain aneurysm, or at parent vessel targeted for occlusion, or other applications.
- the various acts of implant introduction to an aneurysm or parent vessel are considered.
- a number of methods according to the present invention involve the manner in which the delivery system operates in reaching a treatment site, for example.
- Other methods concern the manner in which the system is prepared for delivering an implant, for example attaching the braid ball to the delivery system. Any method herein may be carried out in any order of the recited events which is logically possible, as well as in the recited order of events, or slight modifications of those events or the event order.
Abstract
Description
- This application claims priority to U.S. Provisional Application Ser. No. 61/259,585, filed Nov. 9, 2009, which is incorporated herein by reference in its entirety.
- Commonly-assigned U.S. patent application Ser. No. 12/465,475 to Becking, et al. (also PCT/US2009/041313) describes a new class of braid-based embolization devices and delivery system interfaces. The implants may be used for occluding blood flow at endovascular sites. One use is in intracranial aneurysm embolization or occlusion and another in parent vessel occlusion (PVO) or sacrifice. Improvements to those devices are disclosed herein.
- Braid-ball devices formed with folded-over and folded-flat distal end are among the architectures described in Becking, et al. These architectures are the ones best suited for treating brain aneurysms. Distal marker approaches are described that are especially suited for such devices. In addition, proximal end finishing approaches are described that are suitable for these and the rest of the devices described in Becking et al. All of the features and technologies presented in Becking, et al. (U.S. patent application Ser. No. 12/465,475 and PCT/US2009/041313) are incorporated herein by reference.
- Regarding the distal marker approaches, one improvement comprises a tether to/for the distal marker included in the implant. Specifically, with the marker affixed adjacent the distal end of the implant (as in the folded-flat embodiments in the incorporated application), the length of the tether/tie extends to the proximal hub of the implant. It has a length set so that when the implant is compressed, the marker is pulled into alignment with the implant and/or catheter.
- When a suture is employed for the tether, it can tie around the interior of the distal fold with minimal interference. However, it may be advantageous to use a wire ribbon (e.g., Pt or Nitinol) for other reasons.
- Namely, a tether ribbon (especially when pre-formed into a “V” shape) can be threaded through the gap/hole and around as few as one wire from the braid. So-disposed, there is no interference with the compression of the distal end of the implant. What is more, spring action in the ribbon tether (whether comprising two filaments or trimmed to one after crimping, gluing, welding or otherwise affixing at least one marker) can help position the marker against/across the top of the implant when deployed. Such a ribbon can also contribute to marker radiopacity, thereby allowing a smaller marker size.
- Another option is to include fibers and/or other thrombus promoting material in connection with the tether. Whatever material option is selected and/or additional features are provided, the proximal end of the tether is advantageously captured between the layers of braid or between the braid and either one of optional inner or outer bands. It may be glued-in, affixed by welding or otherwise.
- Yet another set of improvements concerns the manner in which the implant is finished. By “finished”, what is meant is the manner in which the proximal side of the implant is managed to define a hub and/or delivery system detachment interface.
- In one advantageous approach, in which use of an inner band is desired for interface with detachment system components (such as those described in the referenced application), processing is done with an elongate hypotube set within the braid. The hypotube (e.g., about 2-5 cm long) serves as a means to hold and manipulate an implant preform construct. In addition, when the tube is trimmed off (or when the final or near-final implant is trimmed off relative to the tube being held) the remaining portion of the hypotube within the implant (now the “inner band”) defines the detachment interface lumen. Likewise—especially when a more radiopaque material such as Pt/Ir or CoCr is used for the tube, the same structure will improve and/or offer the requisite radiopacity at the proximal end of the implant.
- In all, the approach (optionally characterized as a “sacrificial hypotube length” approach) is useful for gluing but may also be applied in a welding technique. In fact, it may be especially useful in the latter context by providing shielding from weld slag and deformation for the proximal aperture/port to be exposed by trimming the tube to define the inner band in the implant. Namely, after welding, a clean cut can be made (e.g., with a diamond saw, laser cutting, EDM, etc.—as above) and then any deburring (by mechanical action, etching, EP or otherwise) can be performed on the newly-exposed face as desired.
- In conjunction with a sacrificial hypotube length approach for gluing, or the original gluing approach described in the referenced application, another advantageous option is offered by a different post-processing step. Namely, after an outer band is used at the proximal end of the implant to define an outer casting boundary for adhesive/glue (e.g., Loctite 4014), it then may be removed leaving the underlying glue casting in place. Outer band removal offers potential to reduce all of the height, diameter and appearance of the size of the proximal feature of the implant. Accordingly, it may assist in developing a system with 0.021″ catheter crossing profile.
- To facilitate removal, the band may advantageously comprise NiTi alloy (that naturally forms a passivation layer) or it may be coated or otherwise plated. A Titanium Nitride coating may be desirable. Spray mold release (e.g., 3M) or dip-coating in mold release may alternatively be employed to assist in slipping-off the band after adhesive application and curing. Otherwise, the band can be cut off the glue casting.
- Another approach for achieving minimal implant hub diameter—while maintaining necessary radiopacity—involves affixing a platinum band on top of an inner NiTi band (i.e., in a linear arrangement). The proximal/lower NiTi section can be easily welded to the NiTi braid in the ball (when so-constructed) and the Pt (including Pt/Ir and other alloys) provides an in-line radiopaque marker. The detachment system control and anchor wires are received through both bands. The bands may be attached (e.g., by welding, gluing or soldering) or merely associated with each other until detachment system wire removal. In either case, they may include interference fit, puzzle-piece or other groove or tongue-and-groove features to make or assist in making a connection between the bodies.
- Another set of improvements concerns shaping the distal end of a “folded-flat” type implant. It may be provided with a flattened top. The flattened top derives from a flat formed in the round tooling over which the braid is shaped. The flat can be produced by milling about 0.010″ off the form. This depth cut allows sufficient “table” for desired shaping and can be consistently applied across a range of implants sized from about 5 mm to 12 mm in diameter with little effect on the perceived shape. The resulting crease in the implant wire shaped by such a form offers an immediate advantage to implant deployment. With the flat placed so close to the distal end of the device, shape recovery of the bend/crease around the flattened top drives early opening of the implant when unsheathed (as compared to a situation where a crease formed around the flat is set further away—or none is provided).
- Yet another set of implant improvements described herein augments the density of the ball. Stated otherwise, provision is made for an additional layer of braid material to further decrease the braid matrix porosity, and possibly do so without any increase in device crossing profile/delivery (micro)catheter compatibility.
- These improvements involve a third layer of braid that is added to the two layers preferably already present in the folded-flat base implant architecture. In one variation, a third layer of braid is captured between the two layers and captured within the hub region, but trimmed proximal to the distal folded-over/flat section. In another variation, an inner layer is set within the envelope of the aforementioned two layers. It is advantageously attached to a distal end of the inner marker band (above/distal) to any outer marker band provided. As such, the braid's attachment will not increase the hub profile. To avoid any profile increase at the distal end of the implant, the inner layer will typically be trimmed so its compressed length is located proximal to the folded-over braid at the distal end of the implant when compressed. In its unconstrained form, the inner layer may simply define a cup. Alternatively, it may define a secondary ball shape. Such a ball shape may be substantially spherical or ovoid. One advantageous configuration further includes unterminated distal ends to the braid. The ends of the braid defining the inner ball may be secured in a band or welded together. So-configured they can offer another radiopaque marker feature within the ball. However, it may be preferred that the braid ends of the inner layer (in cup, ball form, or otherwise) are unterminated. As such, they may improve thrombus formation within the body of the implant.
- Finally, delivery system improvements are described. The features described are “improvements”—as are the features noted above—in a contextual sense. For example, certain of the delivery system architectures may not be as space-efficient as others. Yet, such larger system(s) may be desirable for reason of reduced manufacturing complexity and/or cost.
- The subject implant and delivery devices, kits in which they are included, methods of use and manufacture are all included within the scope of the present description. A number of aspects of such manufacture are discussed above. More detailed discussion is presented in connection with the figures below.
- The figures provided herein are not necessarily drawn to scale, with some components and features exaggerated for clarity. Variations from the embodiments pictured are contemplated. Accordingly, depiction of aspects and elements of embodiments in the figures are not intended to limit the scope of the description.
- In the figures,
FIGS. 1A and 1B show an implant with a marker tether as expanded and being compressed, respectively; -
FIGS. 2A and 2B show the distal end and a side view of another tethered-marker embodiment, respectively; -
FIG. 3 is a detail view of a marker/tether subassembly; -
FIG. 4 diagrammatically illustrates the assembly inFIG. 3 set within an implant; -
FIG. 5 shows an implant preform prepared for proximal end finishing; -
FIG. 6 shows the proximal end welded; -
FIG. 7 shows an implant preform prepared for proximal end finishing according to another approach; -
FIG. 8 shows the proximal end cut and welded; -
FIGS. 9A and 9B show implants employing alternative proximal end finishing approaches, with a detail view inFIG. 9B of a low-profile embodiment; -
FIGS. 10A and 10B show additional proximal end radiopaque features as may be employed with various end-finishing approaches; -
FIG. 11 shows in implant formed with a distal flattened top; -
FIG. 12 shows implant forms for imparting an implant shape as shown inFIG. 11 across a number of different implants of a given size range; -
FIGS. 13A and 13B , respectively, illustrate the operation of an implant shaped according to FIG. 11/12 as compared to one that is not; -
FIGS. 14-17 diagrammatically illustrate improved density implants as compared to the architecture presented inFIG. 4 ; -
FIG. 18 shows an overview of an implant/detachment system interface as may be employed in connection with the present invention; -
FIGS. 19A-19E and 20A-20E illustrate the stages of operation (handle-side and implant-side, respectively) of the system shown inFIG. 18 ; -
FIG. 21 shows an optional improvement to the architecture of the same system; -
FIGS. 22A and 22B show an alternative delivery system interface engaged and disengaged, respectively; -
FIG. 23 is an end-on view of the delivery system interface as pictured inFIG. 22B . -
FIGS. 24A and 24B illustrate alternative end-on views of the configuration of a pusher shaft in the same system; -
FIGS. 25A and 25B show alternative delivery system interface options (engaged and disengaged, respectively) based on the pusher shaft configuration inFIG. 24B ; -
FIG. 26 shows an alternative implant-side interface with a delivery system as presented inFIGS. 25A and 25B ; -
FIG. 27 shows an implant-side interface like that presented inFIG. 26 with an alternative pusher-side architecture; -
FIGS. 28A and 28B show an alternative engagement/disengagement interface for a system like that shown inFIGS. 22A and 22B ; -
FIGS. 29 and 30 show yet another engagement/disengagement architecture for each of a braid-type implant and embolic coil, respectively. - Various exemplary embodiments are described below. Reference is made to these examples in a non-limiting sense, as it should be noted, that they are provided to illustrate more broadly applicable aspects of the devices, systems and methods. Various changes may be made to these embodiments and equivalents may be substituted without departing from the true spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein.
- To the extent any dimensions are stated in the summary or detailed description, such are intended to be merely examples and are not to limit the inventive subject matter unless explicitly recited in the claims.
- Furthermore, the various features of the embodiments described herein are intended to be complement each other and are not intended to be purely alternatives unless stated so. In other words, features from one embodiment may be freely combined with features of another embodiment, as one of ordinary skill in the art will readily recognize, unless it is stated that those features are only to be used in the alternative. Applicants therefore intend this paragraph to provide written support for any present or future claim that recites features taken from different embodiments, should such not already be clear from the summary, detailed description, and claims.
- Turning to the figures,
FIGS. 1A and 1B show animplant 10. InFIG. 1A , only the hub (not visible) ofimplant 10 is received within a sheath or catheter 2. Roughly 40% ofimplant 10 is received within sheath 2 inFIG. 1B . A radiopaque marker 20 (e.g., a Pt band) is visible in both views. As in Becking, et al., and with further reference toFIG. 4 ,implant 10 includes atie 22 positioned between braid layers 12 and 14 adjacent adistal fold 16 in the braid, which defines aperture 18 (also referred to herein as the hole or gap in the braid).Marker 20 is held bytie 22.Tie 22 may also assist in closing or limiting the size to whichaperture 18 may open. - While
tie 22 terminatesadjacent marker 20 in Becking et al., it extends toproximal hub 30 ofimplant 10 in the present description. The extension “tether” portions, or members, 24 so-provided operate to ensure axial alignment ofmarker 20 whenimplant 10 is captured (especially when re-capturing) in a catheter/sheath. - The length of tether member(s) 24 is therefore set such that slack is present when the implant is expanded (as shown in
FIG. 1A ) and the slack is removed when the implant is fully compressed or tending thereto (as shown inFIG. 1B ). - Whereas the tie and/or tether member shown in
FIGS. 1A and 1B is typically made of suture material, it may be made of any other biocompatible material including stainless steel, titanium, Nitinol (possibly wire that is martinistic at body temperature—commonly referred to as “muscle wire”), and the like. When suture material is employed it can tie around the interior ofdistal fold 16 with minimal interference and be knotted at point 26 (seeFIG. 1A ) to easily secure the position ofmarker 20. The same approach may be accomplished with fine wire (e.g., 0.001 inch round wire.) - It may instead be advantageous to use a wire ribbon (e.g., Pt or Nitinol) for other reasons. A construction as detailed in the next figures was made using a superelastic NiTi ribbon with dimensions set at about 0.001 inches by about 0.003 inches.
- A
tether ribbon 22 heatset into a tight loop or “V” shape was threaded throughgap 20 and around as few as one wire from the braid at a distal end ofimplant 10 as shown inFIG. 4 . So-disposed,tether ribbon 22 does not substantially interfere with compression of the distal end of the implant. What is more, spring action in the tether ribbon (whether comprising two filaments or trimmed to just one filament (as indicated by the broken line) after crimping, gluing, welding or otherwise affixingmarker 20 as shown inFIG. 3 ) can help positionmarker 20 against (or across) the top ofimplant 10 when deployed, as shown inFIGS. 2A and 2B . As for affixing the marker, it is notable that the paired ribbon sections, stacked upon each other, provide a good interface upon which to crimpmarker 20 without drastically altering the marker's shape. - Also, the length of the tether may optionally be set in a general “question-mark” shape to match (or more closely match) the curvature of the implant when unconstrained (e.g., as the tether appears in
FIG. 4 ). Pre-shaping the tether to “match” (or approximately match) one or more implant sizes can help ensure predictable and similar performance of implants across a range of different implant sizes and compressions. - As stated above, another improvement to the subject implants concerns the manner of proximal end finishing.
FIG. 5 shows animplant preform 60 prepared for proximal end finishing. Here, implant preform 60 such as prepared in Becking, et al. is prepared, leaving an additional overhang section 50 extending past aproximal marker band 32. In many respects, the setup resembles that shown in FIG. 13A of Becking et al. with theimplant preform 60 including aninner NiTi tube 34 and the assembly set upon amandrel 52. To maintain the position of the components as shown, glue (e.g., Loctite 4014) is applied. Even so, and referring also toFIG. 6 , thehub region 30 can be welded effectively with aweld bead 54 incorporating the overhanging braid 50,inner tube 34 and at least tack-welding anouter Pt band 32. It is noteworthy that achieving such a near-optimal welding result through (or into) the glue stabilized braid was a surprising result. In other words, it was neither predictable nor expected by those of skill in the art of welding (laser or otherwise). In any case, the length of the braid overhang incorporated intoweld 54 may vary depending on a number of factors including implant diameter, wire diameter, braid density, etc. As shown, the overhang is about 0.005 to about 0.010 inches in length. - Another proximal end finishing approach is described in connection with
FIG. 7 . Specifically, preform 62 is not trimmed and stabilized for welding as shown inFIG. 5 . Rather, preform 62 is prepared upon anelongate hypotube 54. The hypotube body provides a means to hold the construct and stabilize its elongate “tail”section 56 ofbraid layer 12 and/or layer 14 (e.g., by a wrap 58) thereon. - With a narrow window defined (e.g., with about 0.010 to about 0.025 inches of—preferably—exposed braid) laser energy is applied as indicated by the larger area. The energy is sufficient to weld the braid to the hypotube. The welding process does not, however, weld the hypotube to the optional
underlying mandrel 52. - After such welding, the majority of the length of
hypotube 54 is “sacrificed”. It is trimmed-off to define theinner band 34 of the implant as shown inFIG. 8 . This inner band may provide some or all of the radiopacity required in thehub region 30. However an outer band (especially if it comprises Pt) can be tack welded to the braid as indicated by the arrow Z inFIG. 7 . - Irrespective of whether an outer marker band is included,
FIG. 8 illustrates an advantage of the finishing approach, namely, the avoidance of weld bead flow artifacts associated with surface tension at the end of a body (as seen inFIG. 6 ). Rather, theweld 64 is neatly faced and the inner lumen of the remainingband 34 de-burred and/or reamed. Both actual and apparent hub size can be minimized accordingly. -
FIGS. 9A and 9B illustrate another advantageous proximal end finishing approach for minimizing proximal hub size.FIG. 9A shows an implant with anouter marker band 32 as it will generally appear as affixed by glue or welding. In instances where such a band is affixed by glue, once a glue cast is formed therein the band can be removed. Animplant 10′ will then include aproximal hub 30′ that is reduced in diameter (by as much as about 0.004 inches depending on band thickness) and is also less noticeable by offering less contrast. Outside the body (e.g., in packaging) a physician will see a glaze or sheen of adhesive/glue 70 as acast 72 in which the braid is embedded instead of ahigh contrast marker 32. - While seemingly unimportant to function, this visual aspect can indeed be relevant. The impression of physicians regarding the bulk of the proximal feature can affect whether the physician adopts the product. Conventional implants have been designed with the proximal hub completely inset within the inner volume of the implant. This is done to make the implant's appearance more attractive to physicians. However, the implant suffers in performance as a result (e.g., the implant is more difficult to recapture; the requirements on the implant's wire size and strength are heightened to force the implant to recover the inset shape, leading to an undesirable increase in implant dimension; and other performance deficiencies). In the present aspect of the invention, the perceived hub size is reduced, which increases the visual appeal without compromising performance.
-
FIGS. 10A and 10B illustrate additional embodiments that eliminate the outer band while providing relatively increased radiopacity. Specifically, minimal implant hub size can be achieved by relocating a radiopaque band feature to an in-line arrangement with theinner band 34. Asimple Pt band 74 can be set atop theinner band 34 as shown inFIG. 10A . These members may be joined using conventional techniques (i.e., gluing, soldering, welding, etc.) or be held in relation to one another on a temporary basis by utilizing delivery system interface members as shown inFIG. 18 , etc. to the embodiment ofFIG. 10B interlocksmembers - Another implant feature is illustrated in connection with
FIGS. 11 and 12 . The implant optionally includes a flattened top 80 adjacentdistal aperture 18. The flattened top is generated by providing atable surface 82 in themolding element 88 used to define the bulk shape of the implant. Molding elements, or “forms,” indifferent sizes FIG. 12 . They are milled down from a spherical form to define flat 82 surrounded byedge 84. The edge produces acrease 86 in the braid wire. Note that flat 80 andcrease 86 are shown in alternate views inFIGS. 2A and 2B . - During implant preform heatsetting, it has been found that the flat section improves the quality of the
distal fold 16 in the implant, helping to maximize uniformity and minimize the bend radius in the wires. As such, device trackability through tortuous anatomy within a catheter is also improved. The crease at the edge of the flattened area set in the implant also helps with delivery performance upon deployment. Specifically, as illustrated inFIG. 13A , thecrease 86 represents multiple bends in the wires forming the implant braid matrix. Upon exit from the microcatheter, the bends recover and cause the implant distal end to open more than an implant without such a crease as shown inFIG. 13B (see also, the implant inFIG. 1B ). As a more open body, the implant is softer, with more relaxed braid angle should it contact any fragile tissue—such as the dome of an aneurysm. - Other architectural changes or augmentations that may be applied to implants are shown in
FIGS. 14-17 . Each approach offers the potential for diagrammatically improved density relative to the parent architecture illustrated inFIG. 4 . - Specifically,
implant 90 includes an intermediate braid layer 92 set betweenouter layer 12 andinner layer 14. Layer 92 is captured inhub 30 as are the other layers at a proximal attachment 94. Thedistal extent 96 can be set at a number of positions. Advantageously, it extends to around the half-way point or equator of the device. This way, the layer will contribute to implant density (or—stated otherwise—reduce porosity) even for wide-neck aneurysms. - As shown in
FIG. 14 , thedistal extent 96 of the braid is adjacent to the folded-oversection 16 of the implant. Here, the density is highest so the inner layer wires will tend to stay best trapped betweenlayers - In production, the inner layer 92 of the implant can be produced simply by cutting a preform (like preform 62) in half at the distal fold. This produces a set of two inner layer sections that can be used in two different devices from a single formation procedure. However produced, because the inner layer may rely on the other layers for structural definition, it may be made of finer wire and/or with lower braid count than the other layers. For instance, the inner layer may comprise 72-end 0.0008 inch wire braid, whereas the outer layers comprise 96-end 0.0008 inch wire braid. However, the reverse may be true, in which the inner layer is more robust. In any case, it may be advantageous to mismatch the number of wire ends included in the braid (such as in the example directly above) to help avoid wire match-up, thereby minimizing porosity.
-
Implant 100 shown inFIG. 15 illustrates another advantageous approach to improving flow disruption effect, without increasing device crossing profile. As indevice 90, anintermediate braid layer 90 is employed. However its proximal end is not secured within the hub, thereby easing space constraints in that region. - Instead, braid matrix integrity is maintained by coating the braid layer with a polymer (e.g., TICOPHILIC coating by Lubrizol, Inc.) or other coatings or processing. Hydrogel coating also offers an appealing option, such as a hydrogel-based polymer network capable of entrapping therapeutic agents as described in U.S. Pat. No. 6,905,700 to Won et al. Likewise, while the implant elements advantageously comprise Nitinol braid (typically superelastic NiTi), the braid used for any of the layers may instead comprise polymer—especially high strength biodegradable polymer such as MX-2 (MAX-Prene), synthetic absorbable monofilament (90/10 Glycolide/L-Lactide) and/or G-2 (Glycoprene), synthetic absorbable monofilament (Glycolide (PGA), ε-Caprolactone (PCL), Trimethylene Carbonate (TMC) Copolymer) that is heat set into shape (e.g., at 110 degrees centigrade for an hour) and/or coated with the same to stabilize the braid matrix as described.
- Implant 110 shown in
FIG. 16 offers another yet another approach for improved embolizing (or flow disrupting) effect with little or no effect on crossing profile. Such effect is accomplished by affixing an innermost/third braid layer 112 toinner band 34 at its proximal end 114. It may be welded, glued, soldered or otherwise affixed thereto. The distal end of thebraid 116 may be trimmed and formed as shown or otherwise. For example, the cup so-formed may closely follow the inner periphery of the device up to or past its equator. - As with variations in the previous figures, the third layer incorporated in the implant simply deploys and recaptures in unison with the rest of the implant. Unique, however, to the architecture of
FIG. 16 is that the proximal end 114 of the braid is stably secured, but secured such that it does not require space in the hub (e.g., within the outer marker band 32) without dimensional stackup. - A related implant configuration is shown in
FIG. 17 . Here, in implant 120, the same proximal end 114 attachment approach is employed. Yet, instead of forming (e.g., by heatsetting) the inner layer of braid into a cup shape, an inner ball 118 is formed. The proximal side of the ball improves overall proximal-side implant density, and also defines separated flow stagnation zones A and B within the implant to further assist in thrombus formation within the implant. - Inner ball body 118 may be shape set over a form. Alternatively, and more advantageously, the shape can be formed without either an external or internal form by bunching the braid up and tying it onto a mandrel for heatsetting. Such a “free-forming” approach is functionally advantageous because it maximizes braid angle (hence, density) in the final body. Yet, any resulting inconsistency in shape is manageable given that the only outer body of the implant defined by
braid layers - Irrespective of how it is formed (and the particular braid configuration selection) the inner ball 118 within the architecture will be configured so that it will not interfere with the distal end of the implant body/shell and/or marker and tether when the device is compressed for delivery or recapture.
- More generally,
FIG. 18 provides an overview of implant-side of atreatment system 200. The system includes an implant 10 (90, 100, 110, 120) and a pusher/catheter shaft 210 ultimately attached to a handle 220 (e.g., as shown inFIGS. 19A-19-E ). Any of these may be constructed according to the teachings herein and/or incorporated by reference. - One handle construction includes a single plunger. The plunger pulls a collar that progressively engages and pulls sockets connected to the wires; first each
control wire 212 is pulled (one at a time), then theanchor wire 214. Such action is illustrated inFIGS. 19A-19E and 20A-20E.FIGS. 19A and 20A show the device components as removed from packaging.FIG. 19B illustrates unlocking thehandle plunger 222 with a 120 degree rotation relative to handle body 224. Such action has no effect on thedetachment interface 216 shown inFIG. 20B . However, progressive pull of the plunger inFIGS. 19C-19E effect the release of the system as shown inFIGS. 20C-20E . -
FIG. 21 shows an optional improvement to the architecture ofsystem 200. Here,system 200′ has only one “true”control wire 212 is received within the hub orinner band 30/34 of theimplant 10. Even so, the implant remains securely/stably attached to the catheter shaft by virtue of the control wire interaction with anchor ball 216 (e.g., as formed by laser or as otherwise configured). - Release of the implant is effected as if progressing from the steps in
FIGS. 19C and 20C to 19E and 20E. However, a third (floating or actuated) “dummy”wire 218 is still loaded within the lumen ofpusher shaft 210. Use of this wire maintains a close-packed arrangement of the wires insideshaft 210, which can be important in determining wire position within a tortuous setting. Yet, release angle may be increased and plunger pull force reduced because the wires within the implant have more space between them allowing for spatial accommodation. - Note that the length “L” by which
wire 218 is inset within the pusher shaft may vary depending on purpose. It may have no inset (i.e., essentially abut the implant proximal end). It may be inset by about 1 mm so that any forward motion in a tortuous setting does not result in contact with the implant. Or it may be inset to a greater degree (e.g., between about 1 cm and 5 cm) to improve distal tip flexibility ofdelivery pusher shaft 210. -
FIGS. 22A and 22B show an alternative delivery system interface in engaged and disengaged states, respectively. Here,system 230 comprises a catheter/pusher shaft 232 actuated with the assistance of atypical torque 234.Torquer 234 locks a position of acentral wire 236 including an anchor ball forimplant 10 delivery. A bumper orshoulder 240 may be affixed to the catheter (optionally a Pt band also serving as a marker) to abut ahub 30 of the implant for pushing. - Engagement is achieved between the implant and pusher shaft by virtue of
extension 242 that is offset into an interfering relationship with aninner band 34 of the implant when theanchor ball 238 is in a retracted position as shown inFIG. 22A . When wire 236 (and its terminal ball feature 238) is advanced as shown inFIG. 22B ,extension section 242 is free to move (e.g., to return to its original position by elastic action or upon catheter shaft withdrawal) and slide out of the implant. -
FIG. 23 is an end-on view of the delivery system interface as pictured inFIG. 22B . As shown, no interference between theball 238 and/or extension persists oncewire 236 is advanced.FIG. 24A portrays a similar view without the wire in place. It showsextension 242 andcatheter body 232. And while they are illustrated as formed in one manner (i.e., with a 90 degree cut-down), it is to be appreciated that the extension may instead be formed by an angular cut or otherwise. Indeed,FIG. 24B shows an approach in which the extension section is formed by pushing over the catheter wall on one side to meet the other and optionally heat setting, fusing or gluing thecomponent parts -
FIGS. 25A and 25B show an alternativedelivery system interface 250 option (engaged and disengaged, respectively) based on the pusher shaft extension configuration inFIG. 24B . Due to the increased wall thickness offered by the double wall layer, the system can work much as that shown inFIGS. 22A and 22B , except without need for a distal interference feature (i.e., anchor ball/band). As such, withdrawal ofwire 236 will relieve the interference and unlock the pusher shaft 232 (specifically, the associated extension) for withdrawal from theimplant 10. -
FIG. 26 shows an alternative implant-side interface with a delivery system as presented inFIGS. 25A and 25B . Here animplant socket 260 is provided.Socket 260 may be defined by acup 262 attached to one or more implant braid layers (12/14), by welding or otherwise, and a reducer tube 264 threaded, pressed or otherwise affixed in the proximal end of the cup. Note that with such an arrangement that implant pushing can be accomplished without a shoulder or other proximal interface. Instead, both push and pull (for withdrawal) force application can occur within the socket chamber. While such a socket will typically be larger than the previous interfaces shown, it is easily retrofit or used as and alternative to the screw-type release approaches employed in many vessel sacrifice and closure devices as sold by AGA Medical, Inc. and others. - The delivery system configuration in
FIG. 27 shows the same implant-side interface 260, with an alternative pusher-side engagement/disengagement (or latch) architecture 270. This architecture is a simplified version of that shown inFIG. 18 of Becking et al. Specifically, a pusher shaft 272 (e.g., metal hypotube) is provided with asingle window cutout 274. The window (configured as a square cutout, rounded, or a simple kerf) allowing a core member 276 (e.g., NiTi ribbon) to pass therethrough and provide interference against pusher shaft distal face 276 to prevent delivery system detachment until core member withdrawal. -
FIGS. 28A and 28B show analternative latch interface 280 for a system like that shown inFIGS. 22A and 22B . In this system, a bentback wire hook 282 serves the function of the ball in the former system. Such a system offers the advantage of very low cost production, as well as a secure anchoring feature.FIG. 29 shows asystem 290 most closely related to that inFIG. 21 , except that multiple control and/or dummy wires are replaced with asingle ribbon 292. - Finally,
FIG. 30 shows adetachment system 300. As in system 290 aribbon 292 may be used in conjunction with around anchor wire 214 with a ball-shapedanchor 216. An alternative approach that may be used in either system is to employ a ribbon as the “anchor wire” and form the interference feature at its end by tying a knot therein (as a substitute for a laser-formed ball). Such a knot can be shape set, glued or welded to stabilize its shape. It can be reliably be produced at low cost at a very small size, on a ribbon. A socket-type interface can be formed within the coil by fitting a collar feature 302 within its proximal end. The collar may be threaded-in (i.e., into the coils like a thread pitch). An alternative approach involves flowing solder between the coils and defining a lumen therein using a removable mandrel. The mandrel may be prepared in any manner to facilitate its removal, including those described for the removable hub in connection with the improvement described in connection withFIG. 9B . - In the various delivery system architectures, the catheter/pusher shaft comprise a simple extrusion (e.g., PTFE, FEP, PEEK, etc.) or may be constructed using conventional catheter construction techniques and include a liner, braid support and outer jacket (not shown). An exemplary construction is available through MicroLumen, Inc. as Braid Reinforced Polyimide. A distal section of the Polyimide may be ablated and replaced with fused Pebax to provide a softer or progressively-flexible end to the catheter. A loading sheath is typically provided over the pusher shaft. Advantageously, the loading sheath is splittable.
- If not preloaded, after removal from sterile packaging (not shown), the implant is pulled into the loading sheath. The loading sheath is received within the hub of the catheter to be used for implant delivery and the implant is advanced into the catheter. Then, the implant may be advanced to and deployed at a treatment site. Or it may be retrieved in exchange for another size implant—else repositioned, if desired, prior to ultimate detachment as illustrated in the incorporated patent application subject matter.
- In the present invention, the subject methods may include each of the physician activities associated with implant positioning and release. As such, methodology implicit to the positioning and deployment of an implant device forms part of the invention. Such methodology may include placing an implant within a brain aneurysm, or at parent vessel targeted for occlusion, or other applications. In some methods, the various acts of implant introduction to an aneurysm or parent vessel are considered.
- More particularly, a number of methods according to the present invention involve the manner in which the delivery system operates in reaching a treatment site, for example. Other methods concern the manner in which the system is prepared for delivering an implant, for example attaching the braid ball to the delivery system. Any method herein may be carried out in any order of the recited events which is logically possible, as well as in the recited order of events, or slight modifications of those events or the event order.
- It is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Reference to a singular item, includes the possibility that there is a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said,” and “the” include plural referents unless specifically stated otherwise. In other words, use of the articles allow for “at least one” of the subject item in the description above as well as the claims below. It is further noted that the claims may be drafted to exclude any optional element As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation.
- Without the use of such exclusive terminology, the term “comprising” in the claims shall allow for the inclusion of any additional element irrespective of whether a given number of elements are enumerated in the claim, or the addition of a feature could be regarded as transforming the nature of an element set forth in the claims. Except as specifically defined herein, all technical and scientific terms used herein are to be given as broad a commonly understood meaning as possible while maintaining claim validity.
- The breadth of the present invention is not to be limited to the examples provided and/or the subject specification, but rather only by the scope of the claim language. Use of the term “invention” herein is not intended to limit the scope of the claims in any manner. Rather it should be recognized that the “invention” includes the many variations explicitly or implicitly described herein, including those variations that would be obvious to one of ordinary skill in the art upon reading the present specification. Further, it is not intended that any section of this specification (e.g., the Summary, Detailed Description, Abstract, Field of the Invention, etc.) be accorded special significance in describing the invention relative to another or the claims. All references cited are incorporated by reference in their entirety. Although the foregoing invention has been described in detail for purposes of clarity of understanding, it is contemplated that certain modifications may be practiced within the scope of the appended claims.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/942,217 US20110202085A1 (en) | 2009-11-09 | 2010-11-09 | Braid Ball Embolic Device Features |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25958509P | 2009-11-09 | 2009-11-09 | |
US12/942,217 US20110202085A1 (en) | 2009-11-09 | 2010-11-09 | Braid Ball Embolic Device Features |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110202085A1 true US20110202085A1 (en) | 2011-08-18 |
Family
ID=43558291
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/942,217 Abandoned US20110202085A1 (en) | 2009-11-09 | 2010-11-09 | Braid Ball Embolic Device Features |
US12/942,209 Active 2031-03-26 US9095342B2 (en) | 2009-11-09 | 2010-11-09 | Braid ball embolic device features |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/942,209 Active 2031-03-26 US9095342B2 (en) | 2009-11-09 | 2010-11-09 | Braid ball embolic device features |
Country Status (8)
Country | Link |
---|---|
US (2) | US20110202085A1 (en) |
EP (1) | EP2498691B1 (en) |
JP (1) | JP5711251B2 (en) |
CN (1) | CN102791205B (en) |
AU (1) | AU2010314871B2 (en) |
CA (1) | CA2779483C (en) |
ES (1) | ES2534192T3 (en) |
WO (1) | WO2011057277A2 (en) |
Cited By (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8747597B2 (en) | 2008-04-21 | 2014-06-10 | Covidien Lp | Methods for making braid-ball occlusion devices |
US8777978B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8795313B2 (en) | 2011-09-29 | 2014-08-05 | Covidien Lp | Device detachment systems with indicators |
US20150005808A1 (en) * | 2013-06-26 | 2015-01-01 | W. L. Gore & Associates, Inc. | Medical device deployment system |
US8926681B2 (en) | 2010-01-28 | 2015-01-06 | Covidien Lp | Vascular remodeling device |
US8945171B2 (en) | 2011-09-29 | 2015-02-03 | Covidien Lp | Delivery system for implantable devices |
US8974512B2 (en) | 2010-09-10 | 2015-03-10 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
WO2014145012A3 (en) * | 2013-03-15 | 2015-03-26 | Covidien Lp | Delivery and detachment mechanisms for vascular implants |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
US20150105817A1 (en) * | 2008-05-02 | 2015-04-16 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
US9095342B2 (en) | 2009-11-09 | 2015-08-04 | Covidien Lp | Braid ball embolic device features |
US9119948B2 (en) | 2013-02-20 | 2015-09-01 | Covidien Lp | Occlusive implants for hollow anatomical structures, delivery systems, and related methods |
US9179918B2 (en) | 2008-07-22 | 2015-11-10 | Covidien Lp | Vascular remodeling device |
US9259337B2 (en) | 2007-06-04 | 2016-02-16 | Sequent Medical, Inc. | Methods and devices for treatment of vascular defects |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US9375333B1 (en) | 2015-03-06 | 2016-06-28 | Covidien Lp | Implantable device detachment systems and associated devices and methods |
US9393022B2 (en) | 2011-02-11 | 2016-07-19 | Covidien Lp | Two-stage deployment aneurysm embolization devices |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
US9468442B2 (en) | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
US9492174B2 (en) | 2013-08-16 | 2016-11-15 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US9814562B2 (en) | 2009-11-09 | 2017-11-14 | Covidien Lp | Interference-relief type delivery detachment systems |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US20190053810A1 (en) * | 2016-03-11 | 2019-02-21 | Cerus Endovascular Limited | Occlusion device |
US10327781B2 (en) | 2012-11-13 | 2019-06-25 | Covidien Lp | Occlusive devices |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US10478195B2 (en) | 2016-08-04 | 2019-11-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US10675036B2 (en) | 2017-08-22 | 2020-06-09 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10736758B2 (en) | 2013-03-15 | 2020-08-11 | Covidien | Occlusive device |
US10856879B2 (en) | 2015-02-25 | 2020-12-08 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
US10856880B1 (en) | 2019-05-25 | 2020-12-08 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US10874402B2 (en) | 2017-10-10 | 2020-12-29 | Boston Scientific Scimed, Inc. | Detachable RF energized occlusive device |
US10980545B2 (en) | 2016-02-10 | 2021-04-20 | Microvention, Inc. | Devices for vascular occlusion |
US11000287B2 (en) | 2017-08-15 | 2021-05-11 | Boston Scientific Scimed, Inc. | Occlusive medical device system |
US20210251635A1 (en) * | 2020-02-14 | 2021-08-19 | DePuy Synthes Products, Inc. | Intravascular implant deployment system |
US11129621B2 (en) | 2018-12-17 | 2021-09-28 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11147562B2 (en) | 2018-12-12 | 2021-10-19 | DePuy Synthes Products, Inc. | Systems and methods for embolic implant detachment |
US11154412B2 (en) | 2018-02-01 | 2021-10-26 | Boston Scientific Scimed, Inc. | Medical device release system |
US11185335B2 (en) | 2018-01-19 | 2021-11-30 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
US11191927B2 (en) | 2017-07-31 | 2021-12-07 | Boston Scientific Scimed, Inc. | Dilator with engagement region |
US11191558B2 (en) | 2019-06-12 | 2021-12-07 | Covidien Lp | Retrieval of material from corporeal lumens |
US11207494B2 (en) | 2019-07-03 | 2021-12-28 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11253265B2 (en) | 2019-06-18 | 2022-02-22 | DePuy Synthes Products, Inc. | Pull wire detachment for intravascular devices |
US11284901B2 (en) | 2014-04-30 | 2022-03-29 | Cerus Endovascular Limited | Occlusion device |
US11284902B2 (en) | 2018-02-01 | 2022-03-29 | Boston Scientific Scimed, Inc. | Method of making a vascular occlusion device |
US11291453B2 (en) | 2019-03-15 | 2022-04-05 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
US11317921B2 (en) | 2019-03-15 | 2022-05-03 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11376013B2 (en) | 2019-11-18 | 2022-07-05 | DePuy Synthes Products, Inc. | Implant delivery system with braid cup formation |
US11395668B2 (en) | 2019-12-12 | 2022-07-26 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
US11426174B2 (en) | 2019-10-03 | 2022-08-30 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant mechanical release |
US11457922B2 (en) | 2020-01-22 | 2022-10-04 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11471162B2 (en) | 2015-12-07 | 2022-10-18 | Cerus Endovascular Limited | Occlusion device |
US11523838B2 (en) * | 2019-06-12 | 2022-12-13 | Covidien Lp | Retrieval of material from corporeal lumens |
US20230015848A1 (en) * | 2005-01-07 | 2023-01-19 | Stryker Corporation | Intra-Aneurysm Devices |
US11559309B2 (en) | 2019-03-15 | 2023-01-24 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11612430B2 (en) | 2019-03-19 | 2023-03-28 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11633818B2 (en) | 2019-11-04 | 2023-04-25 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11633201B2 (en) | 2017-12-11 | 2023-04-25 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11666350B2 (en) | 2018-06-22 | 2023-06-06 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11672946B2 (en) | 2019-09-24 | 2023-06-13 | Boston Scientific Scimed, Inc. | Protection and actuation mechanism for controlled release of implantable embolic devices |
US11678886B2 (en) | 2014-04-14 | 2023-06-20 | Microvention, Inc. | Devices for therapeutic vascular procedures |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
US11812971B2 (en) | 2017-08-21 | 2023-11-14 | Cerus Endovascular Limited | Occlusion device |
US11826051B2 (en) | 2017-12-21 | 2023-11-28 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube and cylindrical coupling |
US11844490B2 (en) | 2021-12-30 | 2023-12-19 | DePuy Synthes Products, Inc. | Suture linkage for inhibiting premature embolic implant deployment |
US11871931B2 (en) | 2014-08-08 | 2024-01-16 | DePuy Synthes Products, Inc. | Embolic coil delivery system with retractable mechanical release mechanism |
US11931041B2 (en) | 2021-05-10 | 2024-03-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9402707B2 (en) | 2008-07-22 | 2016-08-02 | Neuravi Limited | Clot capture systems and associated methods |
US20110152993A1 (en) * | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
WO2012052982A1 (en) | 2010-10-22 | 2012-04-26 | Neuravi Limited | Clot engagement and removal system |
US11259824B2 (en) | 2011-03-09 | 2022-03-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
WO2012120490A2 (en) | 2011-03-09 | 2012-09-13 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
US20120330341A1 (en) * | 2011-06-22 | 2012-12-27 | Becking Frank P | Folded-Flat Aneurysm Embolization Devices |
CN104185490B (en) | 2012-01-31 | 2017-10-20 | 波士顿科学西美德公司 | Guiding extension conduit |
CN103110444A (en) * | 2013-01-22 | 2013-05-22 | 陈平根 | Biodegradable fabric body capable of being developed and conveying device |
US9662119B2 (en) * | 2013-03-13 | 2017-05-30 | Lawrence Livermore National Security, Llc | Shape-memory polymer foam device for treating aneurysms |
CN105208950A (en) | 2013-03-14 | 2015-12-30 | 尼尔拉维有限公司 | A clot retrieval device for removing occlusive clot from a blood vessel |
WO2014140092A2 (en) | 2013-03-14 | 2014-09-18 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US9433429B2 (en) | 2013-03-14 | 2016-09-06 | Neuravi Limited | Clot retrieval devices |
EP2967574A1 (en) * | 2013-03-15 | 2016-01-20 | Covidien LP | Interference-relief type delivery detachment systems |
US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
CN106999196B (en) | 2014-11-26 | 2020-07-28 | 尼尔拉维有限公司 | Thrombus retrieval device for removing obstructive thrombus from blood vessel |
US11253278B2 (en) | 2014-11-26 | 2022-02-22 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US10617435B2 (en) | 2014-11-26 | 2020-04-14 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US10314593B2 (en) | 2015-09-23 | 2019-06-11 | Covidien Lp | Occlusive devices |
US11517321B2 (en) | 2016-05-26 | 2022-12-06 | Nanostructures, Inc. | System and methods for embolized occlusion of neurovascular aneurysms |
EP3463166A1 (en) | 2016-06-03 | 2019-04-10 | SOMATEX Medical Technologies GmbH | Marking device and implantation system |
US10470773B2 (en) | 2016-06-10 | 2019-11-12 | Terumo Corporation | Vessel occluder |
US20180056043A1 (en) * | 2016-08-29 | 2018-03-01 | Randolf Von Oepen | Adjustable guidewire receiving member |
CA3035706A1 (en) | 2016-09-06 | 2018-03-15 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
EP3528885B1 (en) | 2016-10-18 | 2024-03-13 | Boston Scientific Scimed Inc. | Guide extension catheter |
CN110022789B (en) | 2016-11-23 | 2022-07-12 | 霍罗吉克公司 | Biopsy site marker |
KR20190115474A (en) | 2017-02-23 | 2019-10-11 | 디퍼이 신테스 프로덕츠, 인코포레이티드 | Aneurysm device and delivery system |
US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11589872B2 (en) | 2018-01-31 | 2023-02-28 | Nanostructures, Inc. | Vascular occlusion devices utilizing thin film nitinol foils |
EP3773252A2 (en) | 2018-04-04 | 2021-02-17 | Incumedx Inc. | Embolic device with improved neck coverage |
US11058430B2 (en) | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11596412B2 (en) | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10939915B2 (en) | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11051825B2 (en) | 2018-08-08 | 2021-07-06 | DePuy Synthes Products, Inc. | Delivery system for embolic braid |
US10842498B2 (en) | 2018-09-13 | 2020-11-24 | Neuravi Limited | Systems and methods of restoring perfusion to a vessel |
US11123077B2 (en) | 2018-09-25 | 2021-09-21 | DePuy Synthes Products, Inc. | Intrasaccular device positioning and deployment system |
US11406416B2 (en) | 2018-10-02 | 2022-08-09 | Neuravi Limited | Joint assembly for vasculature obstruction capture device |
US11076861B2 (en) | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11406392B2 (en) | 2018-12-12 | 2022-08-09 | DePuy Synthes Products, Inc. | Aneurysm occluding device for use with coagulating agents |
US11272939B2 (en) | 2018-12-18 | 2022-03-15 | DePuy Synthes Products, Inc. | Intrasaccular flow diverter for treating cerebral aneurysms |
US11134953B2 (en) | 2019-02-06 | 2021-10-05 | DePuy Synthes Products, Inc. | Adhesive cover occluding device for aneurysm treatment |
US11337706B2 (en) | 2019-03-27 | 2022-05-24 | DePuy Synthes Products, Inc. | Aneurysm treatment device |
US11672542B2 (en) | 2019-05-21 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable ball segment |
US11607226B2 (en) | 2019-05-21 | 2023-03-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device with corrugations |
US11413046B2 (en) | 2019-05-21 | 2022-08-16 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11602350B2 (en) | 2019-12-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Intrasaccular inverting braid with highly flexible fill material |
US11278292B2 (en) | 2019-05-21 | 2022-03-22 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system and method |
US11497504B2 (en) | 2019-05-21 | 2022-11-15 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable implanted braid |
US10653425B1 (en) | 2019-05-21 | 2020-05-19 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11712231B2 (en) | 2019-10-29 | 2023-08-01 | Neuravi Limited | Proximal locking assembly design for dual stent mechanical thrombectomy device |
US11517340B2 (en) | 2019-12-03 | 2022-12-06 | Neuravi Limited | Stentriever devices for removing an occlusive clot from a vessel and methods thereof |
US11457926B2 (en) | 2019-12-18 | 2022-10-04 | DePuy Synthes Products, Inc. | Implant having an intrasaccular section and intravascular section |
US11717308B2 (en) | 2020-04-17 | 2023-08-08 | Neuravi Limited | Clot retrieval device for removing heterogeneous clots from a blood vessel |
US11730501B2 (en) | 2020-04-17 | 2023-08-22 | Neuravi Limited | Floating clot retrieval device for removing clots from a blood vessel |
US11871946B2 (en) | 2020-04-17 | 2024-01-16 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
EP4153065A1 (en) * | 2020-05-19 | 2023-03-29 | Boston Scientific Limited | Medical delivery systems and methods of using the same |
US11737771B2 (en) | 2020-06-18 | 2023-08-29 | Neuravi Limited | Dual channel thrombectomy device |
US11439418B2 (en) | 2020-06-23 | 2022-09-13 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11395669B2 (en) | 2020-06-23 | 2022-07-26 | Neuravi Limited | Clot retrieval device with flexible collapsible frame |
US11864781B2 (en) | 2020-09-23 | 2024-01-09 | Neuravi Limited | Rotating frame thrombectomy device |
Citations (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4655771A (en) * | 1982-04-30 | 1987-04-07 | Shepherd Patents S.A. | Prosthesis comprising an expansible or contractile tubular body |
US4998539A (en) * | 1987-12-18 | 1991-03-12 | Delsanti Gerard L | Method of using removable endo-arterial devices to repair detachments in the arterial walls |
US5334210A (en) * | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5378239A (en) * | 1990-04-12 | 1995-01-03 | Schneider (Usa) Inc. | Radially expandable fixation member constructed of recovery metal |
US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5741333A (en) * | 1995-04-12 | 1998-04-21 | Corvita Corporation | Self-expanding stent for a medical device to be introduced into a cavity of a body |
US5749919A (en) * | 1994-01-10 | 1998-05-12 | Microfil Industries S.A. | Resilient prosthesis for widening a channel, particularly a blood vessel, and method for making same |
US5749891A (en) * | 1995-06-06 | 1998-05-12 | Target Therapeutics, Inc. | Multiple layered vaso-occlusive coils |
US5916235A (en) * | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US5925060A (en) * | 1998-03-13 | 1999-07-20 | B. Braun Celsa | Covered self-expanding vascular occlusion device |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US5935148A (en) * | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US5944738A (en) * | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
US6036720A (en) * | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
US6063070A (en) * | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US6086577A (en) * | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US6093199A (en) * | 1998-08-05 | 2000-07-25 | Endovascular Technologies, Inc. | Intra-luminal device for treatment of body cavities and lumens and method of use |
US6152947A (en) * | 1998-04-29 | 2000-11-28 | Embol-X, Inc. | Adjustable blood filtration system |
US6168615B1 (en) * | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US6190402B1 (en) * | 1996-06-21 | 2001-02-20 | Musc Foundation For Research Development | Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same |
US6193708B1 (en) * | 1997-08-05 | 2001-02-27 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (I) |
US6342068B1 (en) * | 1996-04-30 | 2002-01-29 | Schneider (Usa) Inc | Three-dimensional braided stent |
US20020013618A1 (en) * | 1998-02-12 | 2002-01-31 | Marotta Thomas R. | Endovascular prosthesis |
US6346117B1 (en) * | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6350270B1 (en) * | 2000-01-24 | 2002-02-26 | Scimed Life Systems, Inc. | Aneurysm liner |
US6368339B1 (en) * | 1994-07-08 | 2002-04-09 | Aga Medical Corporation | Method of forming medical devices: intra-vascular occlusion devices |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6391037B1 (en) * | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6428558B1 (en) * | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US20030028209A1 (en) * | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
US20030057156A1 (en) * | 2001-03-08 | 2003-03-27 | Dean Peterson | Atrial filter implants |
US6547804B2 (en) * | 2000-12-27 | 2003-04-15 | Scimed Life Systems, Inc. | Selectively permeable highly distensible occlusion balloon |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6585748B1 (en) * | 1997-07-18 | 2003-07-01 | King's Healthcare Nhs Trust Of King's College | Device for treating aneurysms |
US6589265B1 (en) * | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
US6605102B1 (en) * | 1994-07-08 | 2003-08-12 | Ev3, Inc. | Intravascular trap and method of trapping particles in bodily fluids |
US6605111B2 (en) * | 1998-06-04 | 2003-08-12 | New York University | Endovascular thin film devices and methods for treating and preventing stroke |
US6689486B2 (en) * | 2000-02-29 | 2004-02-10 | Ken K. Ho | Bimorphic, compositionally-graded, sputter-deposited, thin film shape memory device |
US20040044391A1 (en) * | 2002-08-29 | 2004-03-04 | Stephen Porter | Device for closure of a vascular defect and method of treating the same |
US6746890B2 (en) * | 2002-07-17 | 2004-06-08 | Tini Alloy Company | Three dimensional thin film devices and methods of fabrication |
US20040122468A1 (en) * | 2002-11-29 | 2004-06-24 | Mindguard Ltd. | Braided intraluminal device for stroke prevention |
US20050010281A1 (en) * | 2001-07-09 | 2005-01-13 | Ofer Yodfat | Implantable intraluminal device and method of using same in treating aneurysms |
US20050033409A1 (en) * | 2001-07-20 | 2005-02-10 | Burke Thomas H. | Aneurysm treatment device and method of use |
US20050033408A1 (en) * | 2001-09-20 | 2005-02-10 | Jones Donald K. | Stent embolization device |
US6855153B2 (en) * | 2001-05-01 | 2005-02-15 | Vahid Saadat | Embolic balloon |
US20050096728A1 (en) * | 2003-10-29 | 2005-05-05 | Marc Ramer | Neck covering device for an aneurysm |
US20050096732A1 (en) * | 2000-08-18 | 2005-05-05 | Marotta Thomas R. | Endovascular prosthesis |
US20050107823A1 (en) * | 2003-11-19 | 2005-05-19 | Leone Jim E. | Anchored stent and occlusive device for treatment of aneurysms |
US6994717B2 (en) * | 1999-03-05 | 2006-02-07 | Board Of Regents, The University Of Texas Systems | Occlusion method and apparatus |
US6994092B2 (en) * | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
US20060052816A1 (en) * | 2004-08-31 | 2006-03-09 | Cook Incorporated | Device for treating an aneurysm |
US7011671B2 (en) * | 2001-07-18 | 2006-03-14 | Atritech, Inc. | Cardiac implant device tether system and method |
US20060064151A1 (en) * | 2004-09-22 | 2006-03-23 | Guterman Lee R | Cranial aneurysm treatment arrangement |
US7029487B2 (en) * | 1998-07-06 | 2006-04-18 | Microvention, Inc. | Vascular embolization with an expansible implant |
US20060116714A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Coupling and release devices and methods for their assembly and use |
US20060155323A1 (en) * | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
US20060167494A1 (en) * | 2005-01-21 | 2006-07-27 | Loubert Suddaby | Aneurysm repair method and apparatus |
US20060190076A1 (en) * | 2003-11-17 | 2006-08-24 | Taheri Syde A | Temporary absorbable venous occlusive stent and superficial vein treatment method |
US20070021816A1 (en) * | 2005-07-21 | 2007-01-25 | The Research Foundation Of State University Of New York | Stent vascular intervention device and methods for treating aneurysms |
US7169177B2 (en) * | 2003-01-15 | 2007-01-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US7195636B2 (en) * | 2001-11-15 | 2007-03-27 | Cordis Neurovascular, Inc. | Aneurysm neck cover for sealing an aneurysm |
US20070088387A1 (en) * | 2005-10-19 | 2007-04-19 | Pulsar Vascular, Inc. | Implantable aneurysm closure systems and methods |
US20070106311A1 (en) * | 2002-04-12 | 2007-05-10 | Boston Scirntific Place | System and method for retaining vaso-occlusive devices within an aneurysm |
US20070162104A1 (en) * | 2000-12-12 | 2007-07-12 | Noureddine Frid | Stent for blood flow improvement |
US20070173928A1 (en) * | 2006-01-23 | 2007-07-26 | Hesham Morsi | Aneurysm sealing device |
US20080021535A1 (en) * | 2003-02-14 | 2008-01-24 | Micrus Corporation, A Delaware Corporation | Intravascular Flow Modifier And Reinforcement Device And Deployment System For Same |
US7331980B2 (en) * | 1998-02-10 | 2008-02-19 | Ethicon Endo-Surgery, Inc. | Occlusion, anchoring, tensioning and flow direction apparatus and methods for use |
US20080097495A1 (en) * | 2004-09-17 | 2008-04-24 | Feller Lll Frederick R | Thin Film Metallic Device for Plugging Aneurysms or Vessels |
US20080119886A1 (en) * | 2006-11-20 | 2008-05-22 | Stout Medical Group. L.P. | Mechanical tissue device and method |
US20080154286A1 (en) * | 2006-12-21 | 2008-06-26 | Ryan Abbott | Systems and Methods for Treating Septal Defects with Capture Devices and Other Devices |
US20090025820A1 (en) * | 2007-07-25 | 2009-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090082803A1 (en) * | 2007-09-26 | 2009-03-26 | Aga Medical Corporation | Braided vascular devices having no end clamps |
US20090112251A1 (en) * | 2007-07-25 | 2009-04-30 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20100030220A1 (en) * | 2008-07-31 | 2010-02-04 | Dfine, Inc. | Bone treatment systems and methods |
US20100069948A1 (en) * | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
US20120041470A1 (en) * | 2006-04-17 | 2012-02-16 | Tyco Healthcare Group Lp | System and method for mechanically positioning intravascular implants |
US20120065720A1 (en) * | 2006-04-17 | 2012-03-15 | Tyco Healthcare Group LP, as successor in interest to Micro Therapeutics,Inc. | System and method for mechanically positioning intravascular implants |
Family Cites Families (233)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4425908A (en) | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US5190546A (en) | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
FR2556210B1 (en) | 1983-12-08 | 1988-04-15 | Barra Jean Aubert | VENOUS PROSTHESIS AND PROCESS FOR PRODUCING THE SAME |
US5749920A (en) | 1983-12-09 | 1998-05-12 | Endovascular Technologies, Inc. | Multicapsule intraluminal grafting system and method |
DK151404C (en) | 1984-05-23 | 1988-07-18 | Cook Europ Aps William | FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD |
EP0257091B1 (en) | 1986-02-24 | 1993-07-28 | Robert E. Fischell | An intravascular stent and percutaneous insertion system |
SE453258B (en) | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
WO1988000813A1 (en) | 1986-08-05 | 1988-02-11 | St. Jude Medical, Inc. | Braided polyester vascular prosthesis and method |
US4921484A (en) * | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
EP0408245B1 (en) | 1989-07-13 | 1994-03-02 | American Medical Systems, Inc. | Stent placement instrument |
CA2026604A1 (en) | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
US5545208A (en) | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5405379A (en) | 1990-07-26 | 1995-04-11 | Lane; Rodney J. | Self expanding vascular endoprosthesis for aneurysms |
US5222971A (en) | 1990-10-09 | 1993-06-29 | Scimed Life Systems, Inc. | Temporary stent and methods for use and manufacture |
USRE38711E1 (en) | 1991-03-08 | 2005-03-15 | Kabushikikaisha Igaki Iryo Sekkei | Luminal stent, holding structure therefor and device for attaching luminal stent |
USRE38653E1 (en) | 1991-03-08 | 2004-11-16 | Kabushikikaisha Igaki Iryo Sekkei | Luminal stent, holding structure therefor and device for attaching luminal stent |
US5766151A (en) | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5232648A (en) | 1991-07-19 | 1993-08-03 | United States Surgical Corporation | Bioabsorbable melt spun fiber based on glycolide-containing copolymer |
US5527338A (en) | 1992-09-02 | 1996-06-18 | Board Of Regents, The University Of Texas System | Intravascular device |
US5250071A (en) | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
EP0596145B1 (en) | 1992-10-31 | 1996-05-08 | Schneider (Europe) Ag | Disposition for implanting a self-expanding endoprothesis |
US5476495A (en) | 1993-03-16 | 1995-12-19 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
WO1994021170A1 (en) | 1993-03-16 | 1994-09-29 | Ep Technologies, Inc. | Flexible circuit assemblies employing ribbon cable |
RU2089131C1 (en) | 1993-12-28 | 1997-09-10 | Сергей Апполонович Пульнев | Stent-expander |
US5549635A (en) | 1994-01-24 | 1996-08-27 | Solar, Rita & Gaterud, Ltd. | Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore |
US20030032963A1 (en) | 2001-10-24 | 2003-02-13 | Kyphon Inc. | Devices and methods using an expandable body with internal restraint for compressing cancellous bone |
AU1938395A (en) | 1994-03-04 | 1995-09-18 | Mentor Corporation | Self-sealing injection sites and method of manufacture |
US5634942A (en) | 1994-04-21 | 1997-06-03 | B. Braun Celsa | Assembly comprising a blood filter for temporary or definitive use and a device for implanting it |
US5846261A (en) | 1994-07-08 | 1998-12-08 | Aga Medical Corp. | Percutaneous catheter directed occlusion devices |
US5690671A (en) | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
US5879366A (en) | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US5814062A (en) | 1994-12-22 | 1998-09-29 | Target Therapeutics, Inc. | Implant delivery assembly with expandable coupling/decoupling mechanism |
US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US5911731A (en) | 1995-04-20 | 1999-06-15 | Target Therapeutics, Inc. | Anatomically shaped vasoocclusive devices |
US5624461A (en) | 1995-06-06 | 1997-04-29 | Target Therapeutics, Inc. | Three dimensional in-filling vaso-occlusive coils |
US6689162B1 (en) | 1995-10-11 | 2004-02-10 | Boston Scientific Scimed, Inc. | Braided composite prosthesis |
US5758562A (en) | 1995-10-11 | 1998-06-02 | Schneider (Usa) Inc. | Process for manufacturing braided composite prosthesis |
EP0775470B1 (en) | 1995-11-14 | 1999-03-24 | Schneider (Europe) GmbH | Stent delivery device |
WO1997025918A1 (en) | 1996-01-19 | 1997-07-24 | Ep Technologies, Inc. | Electrode structures formed from flexible, porous, or woven materials |
US6638293B1 (en) | 1996-02-02 | 2003-10-28 | Transvascular, Inc. | Methods and apparatus for blocking flow through blood vessels |
JP3804690B2 (en) | 1996-03-11 | 2006-08-02 | 鹿島塩ビモノマー株式会社 | Heat recovery method and heat recovery apparatus in thermal decomposition process of 1,2-dichloroethane |
US5853422A (en) | 1996-03-22 | 1998-12-29 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
AR001590A1 (en) | 1996-04-10 | 1997-11-26 | Jorge Alberto Baccaro | Abnormal vascular communications occluder device and applicator cartridge of said device |
US6440088B1 (en) | 1996-05-24 | 2002-08-27 | Precision Vascular Systems, Inc. | Hybrid catheter guide wire apparatus and method |
US6666883B1 (en) | 1996-06-06 | 2003-12-23 | Jacques Seguin | Endoprosthesis for vascular bifurcation |
US6077295A (en) | 1996-07-15 | 2000-06-20 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent delivery system |
US6096034A (en) | 1996-07-26 | 2000-08-01 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US5980514A (en) | 1996-07-26 | 1999-11-09 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US5941249A (en) | 1996-09-05 | 1999-08-24 | Maynard; Ronald S. | Distributed activator for a two-dimensional shape memory alloy |
WO1998012660A1 (en) | 1996-09-23 | 1998-03-26 | Psc Scanning, Inc. | Dithering assemblies for barcode scanners |
US5957974A (en) | 1997-01-23 | 1999-09-28 | Schneider (Usa) Inc | Stent graft with braided polymeric sleeve |
US6096073A (en) | 1997-02-25 | 2000-08-01 | Scimed Life Systems, Inc. | Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel |
US5830230A (en) | 1997-03-07 | 1998-11-03 | Micro Therapeutics, Inc. | Method of intracranial vascular embolotherapy using self anchoring coils |
US5980554A (en) | 1997-05-05 | 1999-11-09 | Micro Therapeutics, Inc. | Wire frame partial flow obstruction for aneurysm treatment |
US5951599A (en) | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US7569066B2 (en) | 1997-07-10 | 2009-08-04 | Boston Scientific Scimed, Inc. | Methods and devices for the treatment of aneurysms |
ES2272007T3 (en) | 1997-08-04 | 2007-04-16 | Boston Scientific Limited | OCLUSION SYSTEM FOR PREPARATION OF AN ANEURISM. |
US6322576B1 (en) | 1997-08-29 | 2001-11-27 | Target Therapeutics, Inc. | Stable coil designs |
US6860893B2 (en) | 1997-08-29 | 2005-03-01 | Boston Scientific Scimed, Inc. | Stable coil designs |
ATE382309T1 (en) | 1997-11-07 | 2008-01-15 | Salviac Ltd | EMBOLIC PROTECTION DEVICE |
US6443972B1 (en) | 1997-11-19 | 2002-09-03 | Cordis Europa N.V. | Vascular filter |
US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US5873907A (en) | 1998-01-27 | 1999-02-23 | Endotex Interventional Systems, Inc. | Electrolytic stent delivery system and methods of use |
US7070607B2 (en) | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
US20070093889A1 (en) | 1999-01-27 | 2007-04-26 | Wu Benjamin M | Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy |
US6676696B1 (en) | 1998-02-12 | 2004-01-13 | Thomas R. Marotta | Endovascular prosthesis |
US6063111A (en) | 1998-03-31 | 2000-05-16 | Cordis Corporation | Stent aneurysm treatment system and method |
EP1083836B1 (en) | 1998-06-01 | 2010-10-13 | Kyphon SÀRL | Expandable preformed structures for deployment in interior body regions |
US6139564A (en) | 1998-06-16 | 2000-10-31 | Target Therapeutics Inc. | Minimally occlusive flow disruptor stent for bridging aneurysm necks |
AU5905599A (en) | 1998-09-04 | 2000-03-27 | Boston Scientific Limited | Detachable aneurysm neck closure patch |
US7410482B2 (en) | 1998-09-04 | 2008-08-12 | Boston Scientific-Scimed, Inc. | Detachable aneurysm neck bridge |
US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US6723112B2 (en) | 1998-11-10 | 2004-04-20 | Scimed Life Systems, Inc. | Bioactive three loop coil |
US6569179B2 (en) | 1998-11-10 | 2003-05-27 | Scimed Life Systems, Inc. | Bioactive three loop coil |
US6325820B1 (en) | 1998-11-16 | 2001-12-04 | Endotex Interventional Systems, Inc. | Coiled-sheet stent-graft with exo-skeleton |
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
WO2000044309A2 (en) | 1999-02-01 | 2000-08-03 | Board Of Regents, The University Of Texas System | Woven bifurcated and trifurcated stents and methods for making the same |
US6695876B1 (en) | 1999-02-12 | 2004-02-24 | Thomas R. Marotta | Endovascular prosthesis |
US6613074B1 (en) | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
US6682505B2 (en) | 1999-03-12 | 2004-01-27 | Arteria Medical Science, Inc. | Catheter for removing emboli from saphenous vein grafts and native coronary arteries |
US6585756B1 (en) | 1999-05-14 | 2003-07-01 | Ernst P. Strecker | Implantable lumen prosthesis |
US6375676B1 (en) | 1999-05-17 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with enhanced delivery precision and stent delivery system |
US6607551B1 (en) | 1999-05-20 | 2003-08-19 | Scimed Life Systems, Inc. | Stent delivery system with nested stabilizer |
US20020169473A1 (en) | 1999-06-02 | 2002-11-14 | Concentric Medical, Inc. | Devices and methods for treating vascular malformations |
US6309367B1 (en) | 1999-07-23 | 2001-10-30 | Neurovasx, Inc. | Aneurysm shield |
US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
US6652555B1 (en) | 1999-10-27 | 2003-11-25 | Atritech, Inc. | Barrier device for covering the ostium of left atrial appendage |
US6331184B1 (en) | 1999-12-10 | 2001-12-18 | Scimed Life Systems, Inc. | Detachable covering for an implantable medical device |
US6312458B1 (en) | 2000-01-19 | 2001-11-06 | Scimed Life Systems, Inc. | Tubular structure/stent/stent securement member |
US6632241B1 (en) | 2000-03-22 | 2003-10-14 | Endovascular Technologies, Inc. | Self-expanding, pseudo-braided intravascular device |
US6530934B1 (en) | 2000-06-06 | 2003-03-11 | Sarcos Lc | Embolic device composed of a linear sequence of miniature beads |
WO2001093782A1 (en) | 2000-06-08 | 2001-12-13 | Frantzen John J | Radially expandable stent featuring covering tip primarily for bifurcated artery aneurysms |
AU2001279261A1 (en) | 2000-06-23 | 2002-01-08 | John J Frantzen | Radially expandable aneurysm treatment stent |
US8298257B2 (en) | 2000-06-29 | 2012-10-30 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
US6855154B2 (en) | 2000-08-11 | 2005-02-15 | University Of Louisville Research Foundation, Inc. | Endovascular aneurysm treatment device and method |
US6635069B1 (en) | 2000-10-18 | 2003-10-21 | Scimed Life Systems, Inc. | Non-overlapping spherical three-dimensional coil |
BE1013757A6 (en) | 2000-12-12 | 2002-07-02 | Frid Noureddine | Luminal endoprosthesis MODULAR. |
US6699274B2 (en) | 2001-01-22 | 2004-03-02 | Scimed Life Systems, Inc. | Stent delivery system and method of manufacturing same |
JP4673987B2 (en) | 2001-02-27 | 2011-04-20 | 株式会社トップ | Stent and stent member |
US6814739B2 (en) | 2001-05-18 | 2004-11-09 | U.S. Endoscopy Group, Inc. | Retrieval device |
ES2355548T3 (en) | 2001-06-11 | 2011-03-28 | Ev3 Inc. | METHOD FOR HANDLING NITINOL WIRE. |
US6692510B2 (en) | 2001-06-14 | 2004-02-17 | Cordis Neurovascular, Inc. | Aneurysm embolization device and deployment system |
US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US7572288B2 (en) | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7485088B2 (en) | 2001-09-05 | 2009-02-03 | Chase Medical L.P. | Method and device for percutaneous surgical ventricular repair |
US6802851B2 (en) | 2001-09-20 | 2004-10-12 | Gordia Neurovascular, Inc. | Stent aneurysm embolization method using collapsible member and embolic coils |
JP4429589B2 (en) | 2001-11-15 | 2010-03-10 | コーディス・ニューロバスキュラー・インコーポレイテッド | Aneurysm embolization device using an occluding member |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US6723116B2 (en) | 2002-01-14 | 2004-04-20 | Syde A. Taheri | Exclusion of ascending/descending aorta and/or aortic arch aneurysm |
US6989024B2 (en) | 2002-02-28 | 2006-01-24 | Counter Clockwise, Inc. | Guidewire loaded stent for delivery through a catheter |
US20030176884A1 (en) * | 2002-03-12 | 2003-09-18 | Marwane Berrada | Everted filter device |
US7695488B2 (en) | 2002-03-27 | 2010-04-13 | Boston Scientific Scimed, Inc. | Expandable body cavity liner device |
US20030195609A1 (en) | 2002-04-10 | 2003-10-16 | Scimed Life Systems, Inc. | Hybrid stent |
US6698877B2 (en) | 2002-06-28 | 2004-03-02 | Kimberly-Clark Worldwide, Inc. | Offset printing apparatus for applying a substance |
US20040172056A1 (en) | 2002-07-12 | 2004-09-02 | Guterman Lee R. | Bifurcated aneurysm buttress arrangement |
US20040015224A1 (en) | 2002-07-22 | 2004-01-22 | Armstrong Joseph R. | Endoluminal expansion system |
JP2004049585A (en) | 2002-07-22 | 2004-02-19 | Piolax Medical Device:Kk | Stent type therapeutic instrument |
US20040034386A1 (en) | 2002-08-19 | 2004-02-19 | Michael Fulton | Aneurysm stent |
US8075585B2 (en) | 2002-08-29 | 2011-12-13 | Stryker Corporation | Device and method for treatment of a vascular defect |
US7063679B2 (en) | 2002-09-20 | 2006-06-20 | Flowmedica, Inc. | Intra-aortic renal delivery catheter |
FR2847155B1 (en) | 2002-11-20 | 2005-08-05 | Younes Boudjemline | METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY |
US20040111112A1 (en) | 2002-11-20 | 2004-06-10 | Hoffmann Gerard Von | Method and apparatus for retaining embolic material |
US20040143286A1 (en) | 2003-01-17 | 2004-07-22 | Johnson Eric G. | Catheter with disruptable guidewire channel |
US7744583B2 (en) | 2003-02-03 | 2010-06-29 | Boston Scientific Scimed | Systems and methods of de-endothelialization |
US20040193246A1 (en) | 2003-03-25 | 2004-09-30 | Microvention, Inc. | Methods and apparatus for treating aneurysms and other vascular defects |
US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
WO2004103450A1 (en) | 2003-05-23 | 2004-12-02 | Kabushikikaisha Igaki Iryo Sekkei | Stent supplying device |
US7470282B2 (en) | 2003-06-30 | 2008-12-30 | Boston Scientific Scimed, Inc. | Stent grip and system for use therewith |
DE10335649A1 (en) | 2003-07-30 | 2005-02-24 | Jotec Gmbh | Braid stent for implantation in a blood vessel |
JP2007020590A (en) | 2003-08-19 | 2007-02-01 | Institute Of Physical & Chemical Research | Material for aneurysm curing |
US20050060017A1 (en) | 2003-09-15 | 2005-03-17 | Fischell Robert E. | Means and method for the treatment of cerebral aneurysms |
US7763011B2 (en) | 2003-12-22 | 2010-07-27 | Boston Scientific Scimed, Inc. | Variable density braid stent |
US20110208233A1 (en) | 2004-01-22 | 2011-08-25 | Mcguckin Jr James F | Device for preventing clot migration from left atrial appendage |
US8211140B2 (en) | 2004-01-22 | 2012-07-03 | Rex Medical, L.P. | Vein filter |
US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US20050228434A1 (en) | 2004-03-19 | 2005-10-13 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8915952B2 (en) | 2004-03-31 | 2014-12-23 | Merlin Md Pte Ltd. | Method for treating aneurysms |
EA009163B1 (en) | 2004-04-08 | 2007-10-26 | Ага Медикал Корпорейшн | Flange occlusion devices and methods |
WO2005110240A1 (en) | 2004-05-07 | 2005-11-24 | Nmt Medical, Inc. | Catching mechanisms for tubular septal occluder |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US20060206200A1 (en) | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
EP1750619B1 (en) | 2004-05-25 | 2013-07-24 | Covidien LP | Flexible vascular occluding device |
BE1016067A3 (en) | 2004-06-03 | 2006-02-07 | Frid Noureddine | Luminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT. |
US7699056B2 (en) | 2004-06-10 | 2010-04-20 | Conceptus, Inc. | Medical devices and methods of making and using such devices |
US20060025801A1 (en) | 2004-07-30 | 2006-02-02 | Robert Lulo | Embolic device deployment system with filament release |
EP1789123A4 (en) | 2004-09-17 | 2010-03-03 | Cordis Neurovascular Inc | Thin film metallic devices for plugging aneurysms or vessels |
WO2006034149A2 (en) | 2004-09-17 | 2006-03-30 | Cordis Neurovascular, Inc. | Expandable vascular occlusion device |
US20060106421A1 (en) | 2004-11-16 | 2006-05-18 | Clifford Teoh | Expansible neck bridge |
US20060116713A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US7608089B2 (en) | 2004-12-22 | 2009-10-27 | Boston Scientific Scimed, Inc. | Vaso-occlusive device having pivotable coupling |
AU2006211015B2 (en) | 2005-02-04 | 2010-12-16 | Zuli Holdings, Ltd. | Device and methods for non-surgical clipping of aneurysms |
US20060190070A1 (en) | 2005-02-23 | 2006-08-24 | Dieck Martin S | Rail stent and methods of use |
WO2006095309A2 (en) | 2005-03-07 | 2006-09-14 | Koninklijke Philips Electronics N.V. | Apparatus and method for correlating first and second 3d images of tubular object |
US20060206199A1 (en) | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices |
US20060264905A1 (en) | 2005-05-02 | 2006-11-23 | Pulsar Vascular, Inc. | Improved Catheters |
US20060264907A1 (en) | 2005-05-02 | 2006-11-23 | Pulsar Vascular, Inc. | Catheters having stiffening mechanisms |
WO2006119422A2 (en) | 2005-05-02 | 2006-11-09 | Pulsar Vascular, Incorporated | Improved catheters |
JP5144504B2 (en) | 2005-05-11 | 2013-02-13 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | Device for visceral surgery |
JP4945714B2 (en) | 2005-05-25 | 2012-06-06 | タイコ ヘルスケア グループ リミテッド パートナーシップ | System and method for supplying and deploying an occlusion device in a conduit |
US20060276827A1 (en) | 2005-06-02 | 2006-12-07 | Vladimir Mitelberg | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7708754B2 (en) | 2005-06-02 | 2010-05-04 | Codman & Shurtleff, Pc | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7963988B2 (en) | 2005-06-23 | 2011-06-21 | Boston Scientific Scimed, Inc. | ePTFE lamination—resizing ePTFE tubing |
US20080058856A1 (en) | 2005-06-28 | 2008-03-06 | Venkatesh Ramaiah | Non-occluding dilation device |
US20070016243A1 (en) | 2005-06-28 | 2007-01-18 | Venkatesh Ramaiah | Non-occlusive, retrievable dilation system |
US20080114439A1 (en) | 2005-06-28 | 2008-05-15 | Venkatesh Ramaiah | Non-occluding dilation device |
FR2890306B1 (en) | 2005-09-08 | 2007-11-02 | Beatrix Jean | DEVICE FOR THE TREATMENT OF A VASCULAR POCKET |
US7972359B2 (en) | 2005-09-16 | 2011-07-05 | Atritech, Inc. | Intracardiac cage and method of delivering same |
US7550053B2 (en) | 2006-01-26 | 2009-06-23 | Ilh, Llc | Catheters with lubricious linings and methods for making and using them |
EP1942972B1 (en) | 2005-10-05 | 2017-09-27 | Balt Extrusion | Safety catheter for fluid injection |
BRPI0617652A2 (en) | 2005-10-19 | 2011-08-02 | Pulsar Vascular Inc | methods and systems for endovascular incision and repair of tissue and lumen defects |
US20070219619A1 (en) | 2005-10-27 | 2007-09-20 | Cardiovasc, Inc. | Partially covered stent devices and methods of use |
US20070135826A1 (en) * | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
WO2007076480A2 (en) | 2005-12-23 | 2007-07-05 | Levy Elad I | Bifurcated aneurysm treatment arrangement |
US7691124B2 (en) | 2006-01-31 | 2010-04-06 | Codman & Shurtleff, Inc. | Delivery of therapeutic devices |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
DE102006013770A1 (en) | 2006-03-24 | 2007-09-27 | Occlutech Gmbh | Occlusion instrument and method for its production |
WO2008051279A1 (en) | 2006-03-24 | 2008-05-02 | Biomerix Corp | Self-expandable endovascular device for aneurysm occlusion |
US20070233244A1 (en) | 2006-03-28 | 2007-10-04 | Depuy Spine, Inc. | Artificial Disc Replacement Using Posterior Approach |
US20070239261A1 (en) | 2006-04-07 | 2007-10-11 | Arani Bose | Aneurysm occlusion system and method |
EP1849440A1 (en) | 2006-04-28 | 2007-10-31 | Younes Boudjemline | Vascular stents with varying diameter |
WO2007134266A2 (en) | 2006-05-12 | 2007-11-22 | Electroformed Stents, Inc. | Exclusion device and system for delivery |
US7906066B2 (en) | 2006-06-30 | 2011-03-15 | Abbott Cardiovascular Systems, Inc. | Method of making a balloon catheter shaft having high strength and flexibility |
EP2037848A1 (en) | 2006-07-07 | 2009-03-25 | Boston Scientific Limited | Endoprosthesis delivery system with stent holder |
US20080114436A1 (en) | 2006-08-17 | 2008-05-15 | Dieck Martin S | Aneurysm covering devices and delivery devices |
JP2010500915A (en) | 2006-08-17 | 2010-01-14 | エヌフォーカス ニューロメディカル, インコーポレイテッド | Aneurysm isolation device |
US8460335B2 (en) | 2006-09-11 | 2013-06-11 | Embrella Cardiovascular, Inc. | Method of deflecting emboli from the cerebral circulation |
WO2008063455A1 (en) | 2006-11-13 | 2008-05-29 | Hines Richard A | Over-the wire exclusion device and system for delivery |
WO2008074027A1 (en) * | 2006-12-13 | 2008-06-19 | Biomerix Corporation | Aneurysm occlusion devices |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
EP2157937B1 (en) | 2007-06-04 | 2017-03-22 | Sequent Medical, Inc. | Devices for treatment of vascular defects |
WO2008157507A2 (en) | 2007-06-15 | 2008-12-24 | Nfocus Neuromedical, Inc. | Blood flow diverters and aneurysm covering devices |
US20080319533A1 (en) | 2007-06-22 | 2008-12-25 | Neurovasx, Inc. | Aneurysm occlusion assist device |
EP2190380A1 (en) | 2007-09-11 | 2010-06-02 | NFocus Neuromedical, Inc. | Aneurysm cover device for embolic delivery and retention |
US9414842B2 (en) | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
DE102008028308A1 (en) | 2007-10-18 | 2009-04-23 | Acandis Gmbh & Co. Kg | Vascular implant for treating cerebral posterior circulation aneurysm, has lattice structure with deflection unit forming cone with apex that faces structure or three-dimensional curvature that extends towards axial end of structure |
US20090118811A1 (en) | 2007-11-05 | 2009-05-07 | Medtronic Vascular, Inc. | Globe Stent |
WO2009073553A1 (en) | 2007-11-30 | 2009-06-11 | Cook Incorporated | Method and device for vascular therapy |
US8728141B2 (en) | 2007-12-11 | 2014-05-20 | Cornell University | Method and apparatus for sealing an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while maintaining substantially normal flow through the body lumen |
US8163004B2 (en) | 2008-02-18 | 2012-04-24 | Aga Medical Corporation | Stent graft for reinforcement of vascular abnormalities and associated method |
US20090228029A1 (en) | 2008-03-05 | 2009-09-10 | Neuro Vasx, Inc. | Aneurysm shield anchoring device |
EP3970633A1 (en) | 2008-04-21 | 2022-03-23 | Covidien LP | Braid-ball embolic devices and delivery systems |
US8974487B2 (en) | 2008-05-01 | 2015-03-10 | Aneuclose Llc | Aneurysm occlusion device |
US9597087B2 (en) | 2008-05-02 | 2017-03-21 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US8128617B2 (en) | 2008-05-27 | 2012-03-06 | Boston Scientific Scimed, Inc. | Electrical mapping and cryo ablating with a balloon catheter |
US7869889B2 (en) | 2008-07-02 | 2011-01-11 | Saudi Arabian Oil Company | Distributed and adaptive smart logic with multi-communication apparatus for reliable safety system shutdown |
CN102137626A (en) | 2008-07-22 | 2011-07-27 | 微治疗公司 | Vascular remodeling device |
ES2879278T3 (en) | 2008-09-05 | 2021-11-22 | Pulsar Vascular Inc | Systems to support or occlude a physiological opening or cavity |
US20100131002A1 (en) | 2008-11-24 | 2010-05-27 | Connor Robert A | Stent with a net layer to embolize and aneurysm |
CA2750222C (en) | 2009-01-22 | 2018-02-27 | Cornell University | Method and apparatus for restricting flow through the wall of a lumen |
US20100274276A1 (en) | 2009-04-22 | 2010-10-28 | Ricky Chow | Aneurysm treatment system, device and method |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
US20110152993A1 (en) | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
US20110202085A1 (en) | 2009-11-09 | 2011-08-18 | Siddharth Loganathan | Braid Ball Embolic Device Features |
US9814562B2 (en) | 2009-11-09 | 2017-11-14 | Covidien Lp | Interference-relief type delivery detachment systems |
EP2528541B1 (en) | 2010-01-28 | 2016-05-18 | Covidien LP | Vascular remodeling device |
CN102740799A (en) | 2010-01-28 | 2012-10-17 | 泰科保健集团有限合伙公司 | Vascular remodeling device |
WO2011130081A1 (en) | 2010-04-14 | 2011-10-20 | Microvention, Inc. | Implant delivery device |
US20110301630A1 (en) | 2010-06-02 | 2011-12-08 | Cook Incorporated | Occlusion device |
US9351859B2 (en) | 2010-12-06 | 2016-05-31 | Covidien Lp | Vascular remodeling device |
EP2675402A4 (en) | 2011-02-18 | 2015-11-04 | Sequent Medical Inc | Blood flow disruption devices and methods for the treatment of vascular defects |
US20120245674A1 (en) | 2011-03-25 | 2012-09-27 | Tyco Healthcare Group Lp | Vascular remodeling device |
US20120283768A1 (en) | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
US20120330341A1 (en) | 2011-06-22 | 2012-12-27 | Becking Frank P | Folded-Flat Aneurysm Embolization Devices |
WO2013049448A1 (en) | 2011-09-29 | 2013-04-04 | Covidien Lp | Vascular remodeling device |
US8261648B1 (en) | 2011-10-17 | 2012-09-11 | Sequent Medical Inc. | Braiding mechanism and methods of use |
CN106192198B (en) | 2011-10-17 | 2020-06-05 | 后续医疗股份有限公司 | Knitting mechanism |
-
2010
- 2010-11-09 US US12/942,217 patent/US20110202085A1/en not_active Abandoned
- 2010-11-09 CA CA2779483A patent/CA2779483C/en active Active
- 2010-11-09 JP JP2012538088A patent/JP5711251B2/en active Active
- 2010-11-09 AU AU2010314871A patent/AU2010314871B2/en not_active Ceased
- 2010-11-09 WO PCT/US2010/056051 patent/WO2011057277A2/en active Application Filing
- 2010-11-09 US US12/942,209 patent/US9095342B2/en active Active
- 2010-11-09 CN CN201080056668.8A patent/CN102791205B/en active Active
- 2010-11-09 EP EP10785550.4A patent/EP2498691B1/en active Active
- 2010-11-09 ES ES10785550.4T patent/ES2534192T3/en active Active
Patent Citations (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4655771A (en) * | 1982-04-30 | 1987-04-07 | Shepherd Patents S.A. | Prosthesis comprising an expansible or contractile tubular body |
US4655771B1 (en) * | 1982-04-30 | 1996-09-10 | Medinvent Ams Sa | Prosthesis comprising an expansible or contractile tubular body |
US4998539A (en) * | 1987-12-18 | 1991-03-12 | Delsanti Gerard L | Method of using removable endo-arterial devices to repair detachments in the arterial walls |
US5378239A (en) * | 1990-04-12 | 1995-01-03 | Schneider (Usa) Inc. | Radially expandable fixation member constructed of recovery metal |
US5334210A (en) * | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5749919A (en) * | 1994-01-10 | 1998-05-12 | Microfil Industries S.A. | Resilient prosthesis for widening a channel, particularly a blood vessel, and method for making same |
US6579303B2 (en) * | 1994-07-08 | 2003-06-17 | Aga Medical Corporation | Method of forming medical device; intravascular occlusion device |
US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US6368339B1 (en) * | 1994-07-08 | 2002-04-09 | Aga Medical Corporation | Method of forming medical devices: intra-vascular occlusion devices |
US6682546B2 (en) * | 1994-07-08 | 2004-01-27 | Aga Medical Corporation | Intravascular occlusion devices |
US6605102B1 (en) * | 1994-07-08 | 2003-08-12 | Ev3, Inc. | Intravascular trap and method of trapping particles in bodily fluids |
US6599308B2 (en) * | 1994-07-08 | 2003-07-29 | Aga Medical Corporation | Intravascular occlusion devices |
US5741333A (en) * | 1995-04-12 | 1998-04-21 | Corvita Corporation | Self-expanding stent for a medical device to be introduced into a cavity of a body |
US5749891A (en) * | 1995-06-06 | 1998-05-12 | Target Therapeutics, Inc. | Multiple layered vaso-occlusive coils |
US6033423A (en) * | 1995-06-06 | 2000-03-07 | Target Therapeutics, Inc. | Multiple layered vaso-occlusive coils |
US20010000797A1 (en) * | 1996-01-24 | 2001-05-03 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US6506204B2 (en) * | 1996-01-24 | 2003-01-14 | Aga Medical Corporation | Method and apparatus for occluding aneurysms |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US6342068B1 (en) * | 1996-04-30 | 2002-01-29 | Schneider (Usa) Inc | Three-dimensional braided stent |
US6190402B1 (en) * | 1996-06-21 | 2001-02-20 | Musc Foundation For Research Development | Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6344048B1 (en) * | 1997-07-10 | 2002-02-05 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6780196B2 (en) * | 1997-07-10 | 2004-08-24 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US7229461B2 (en) * | 1997-07-10 | 2007-06-12 | Boston Scientific Scimed, Inc. | Removable occlusion system for aneurysm neck |
US6585748B1 (en) * | 1997-07-18 | 2003-07-01 | King's Healthcare Nhs Trust Of King's College | Device for treating aneurysms |
US6193708B1 (en) * | 1997-08-05 | 2001-02-27 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (I) |
US6063070A (en) * | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US6936055B1 (en) * | 1997-08-05 | 2005-08-30 | Scime Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US6383174B1 (en) * | 1997-08-05 | 2002-05-07 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (II) |
US5916235A (en) * | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US6086577A (en) * | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US6036720A (en) * | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
US5944738A (en) * | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
US7331980B2 (en) * | 1998-02-10 | 2008-02-19 | Ethicon Endo-Surgery, Inc. | Occlusion, anchoring, tensioning and flow direction apparatus and methods for use |
US20020013618A1 (en) * | 1998-02-12 | 2002-01-31 | Marotta Thomas R. | Endovascular prosthesis |
US5925060A (en) * | 1998-03-13 | 1999-07-20 | B. Braun Celsa | Covered self-expanding vascular occlusion device |
US6221086B1 (en) * | 1998-03-13 | 2001-04-24 | B. Braun Medical Sas | Covered self-expanding vascular occlusion device |
US6589256B2 (en) * | 1998-03-13 | 2003-07-08 | B. Braun Medical Sas | Covered self-expanding vascular occlusion device |
US20010012949A1 (en) * | 1998-03-13 | 2001-08-09 | Forber Simon J. | Covered self-expanding vascular occlusion device |
US6152947A (en) * | 1998-04-29 | 2000-11-28 | Embol-X, Inc. | Adjustable blood filtration system |
US6168615B1 (en) * | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US6605111B2 (en) * | 1998-06-04 | 2003-08-12 | New York University | Endovascular thin film devices and methods for treating and preventing stroke |
US5935148A (en) * | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US6063104A (en) * | 1998-06-24 | 2000-05-16 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US7029487B2 (en) * | 1998-07-06 | 2006-04-18 | Microvention, Inc. | Vascular embolization with an expansible implant |
US6093199A (en) * | 1998-08-05 | 2000-07-25 | Endovascular Technologies, Inc. | Intra-luminal device for treatment of body cavities and lumens and method of use |
US6994717B2 (en) * | 1999-03-05 | 2006-02-07 | Board Of Regents, The University Of Texas Systems | Occlusion method and apparatus |
US6428558B1 (en) * | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
US6746468B1 (en) * | 1999-06-02 | 2004-06-08 | Concentric Medical, Inc. | Devices and methods for treating vascular malformations |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6730108B2 (en) * | 1999-10-27 | 2004-05-04 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6994092B2 (en) * | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
US6350270B1 (en) * | 2000-01-24 | 2002-02-26 | Scimed Life Systems, Inc. | Aneurysm liner |
US6689486B2 (en) * | 2000-02-29 | 2004-02-10 | Ken K. Ho | Bimorphic, compositionally-graded, sputter-deposited, thin film shape memory device |
US6391037B1 (en) * | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6346117B1 (en) * | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US20050096732A1 (en) * | 2000-08-18 | 2005-05-05 | Marotta Thomas R. | Endovascular prosthesis |
US6589265B1 (en) * | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
US20070162104A1 (en) * | 2000-12-12 | 2007-07-12 | Noureddine Frid | Stent for blood flow improvement |
US6547804B2 (en) * | 2000-12-27 | 2003-04-15 | Scimed Life Systems, Inc. | Selectively permeable highly distensible occlusion balloon |
US20030057156A1 (en) * | 2001-03-08 | 2003-03-27 | Dean Peterson | Atrial filter implants |
US6855153B2 (en) * | 2001-05-01 | 2005-02-15 | Vahid Saadat | Embolic balloon |
US20050010281A1 (en) * | 2001-07-09 | 2005-01-13 | Ofer Yodfat | Implantable intraluminal device and method of using same in treating aneurysms |
US20080039933A1 (en) * | 2001-07-09 | 2008-02-14 | Surpass Medical Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US7011671B2 (en) * | 2001-07-18 | 2006-03-14 | Atritech, Inc. | Cardiac implant device tether system and method |
US20050033409A1 (en) * | 2001-07-20 | 2005-02-10 | Burke Thomas H. | Aneurysm treatment device and method of use |
US20030028209A1 (en) * | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
US20050033408A1 (en) * | 2001-09-20 | 2005-02-10 | Jones Donald K. | Stent embolization device |
US7195636B2 (en) * | 2001-11-15 | 2007-03-27 | Cordis Neurovascular, Inc. | Aneurysm neck cover for sealing an aneurysm |
US20070106311A1 (en) * | 2002-04-12 | 2007-05-10 | Boston Scirntific Place | System and method for retaining vaso-occlusive devices within an aneurysm |
US6746890B2 (en) * | 2002-07-17 | 2004-06-08 | Tini Alloy Company | Three dimensional thin film devices and methods of fabrication |
US20040044391A1 (en) * | 2002-08-29 | 2004-03-04 | Stephen Porter | Device for closure of a vascular defect and method of treating the same |
US20040122468A1 (en) * | 2002-11-29 | 2004-06-24 | Mindguard Ltd. | Braided intraluminal device for stroke prevention |
US7169177B2 (en) * | 2003-01-15 | 2007-01-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20080021535A1 (en) * | 2003-02-14 | 2008-01-24 | Micrus Corporation, A Delaware Corporation | Intravascular Flow Modifier And Reinforcement Device And Deployment System For Same |
US20050096728A1 (en) * | 2003-10-29 | 2005-05-05 | Marc Ramer | Neck covering device for an aneurysm |
US7232461B2 (en) * | 2003-10-29 | 2007-06-19 | Cordis Neurovascular, Inc. | Neck covering device for an aneurysm |
US20060190076A1 (en) * | 2003-11-17 | 2006-08-24 | Taheri Syde A | Temporary absorbable venous occlusive stent and superficial vein treatment method |
US20050107823A1 (en) * | 2003-11-19 | 2005-05-19 | Leone Jim E. | Anchored stent and occlusive device for treatment of aneurysms |
US20060052816A1 (en) * | 2004-08-31 | 2006-03-09 | Cook Incorporated | Device for treating an aneurysm |
US20080097495A1 (en) * | 2004-09-17 | 2008-04-24 | Feller Lll Frederick R | Thin Film Metallic Device for Plugging Aneurysms or Vessels |
US20060064151A1 (en) * | 2004-09-22 | 2006-03-23 | Guterman Lee R | Cranial aneurysm treatment arrangement |
US20060116714A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Coupling and release devices and methods for their assembly and use |
US20060155323A1 (en) * | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
US20060167494A1 (en) * | 2005-01-21 | 2006-07-27 | Loubert Suddaby | Aneurysm repair method and apparatus |
US20070021816A1 (en) * | 2005-07-21 | 2007-01-25 | The Research Foundation Of State University Of New York | Stent vascular intervention device and methods for treating aneurysms |
US20070088387A1 (en) * | 2005-10-19 | 2007-04-19 | Pulsar Vascular, Inc. | Implantable aneurysm closure systems and methods |
US20070173928A1 (en) * | 2006-01-23 | 2007-07-26 | Hesham Morsi | Aneurysm sealing device |
US20120041470A1 (en) * | 2006-04-17 | 2012-02-16 | Tyco Healthcare Group Lp | System and method for mechanically positioning intravascular implants |
US20120065720A1 (en) * | 2006-04-17 | 2012-03-15 | Tyco Healthcare Group LP, as successor in interest to Micro Therapeutics,Inc. | System and method for mechanically positioning intravascular implants |
US20080119886A1 (en) * | 2006-11-20 | 2008-05-22 | Stout Medical Group. L.P. | Mechanical tissue device and method |
US20100152767A1 (en) * | 2006-11-20 | 2010-06-17 | Septrx, Inc. | Mechanical Tissue Device and Method |
US20080154286A1 (en) * | 2006-12-21 | 2008-06-26 | Ryan Abbott | Systems and Methods for Treating Septal Defects with Capture Devices and Other Devices |
US20090025820A1 (en) * | 2007-07-25 | 2009-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090112251A1 (en) * | 2007-07-25 | 2009-04-30 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090082803A1 (en) * | 2007-09-26 | 2009-03-26 | Aga Medical Corporation | Braided vascular devices having no end clamps |
US20100030220A1 (en) * | 2008-07-31 | 2010-02-04 | Dfine, Inc. | Bone treatment systems and methods |
US20100069948A1 (en) * | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
Cited By (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230015848A1 (en) * | 2005-01-07 | 2023-01-19 | Stryker Corporation | Intra-Aneurysm Devices |
US8864790B2 (en) | 2006-04-17 | 2014-10-21 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8795320B2 (en) | 2006-04-17 | 2014-08-05 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8795321B2 (en) | 2006-04-17 | 2014-08-05 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8777978B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US11179159B2 (en) | 2007-06-04 | 2021-11-23 | Sequent Medical, Inc. | Methods and devices for treatment of vascular defects |
US9259337B2 (en) | 2007-06-04 | 2016-02-16 | Sequent Medical, Inc. | Methods and devices for treatment of vascular defects |
US11844528B2 (en) | 2008-04-21 | 2023-12-19 | Covidien Lp | Multiple layer filamentary devices for treatment of vascular defects |
US9039726B2 (en) | 2008-04-21 | 2015-05-26 | Covidien Lp | Filamentary devices for treatment of vascular defects |
US8747597B2 (en) | 2008-04-21 | 2014-06-10 | Covidien Lp | Methods for making braid-ball occlusion devices |
US9585669B2 (en) | 2008-04-21 | 2017-03-07 | Covidien Lp | Multiple layer filamentary devices for treatment of vascular defects |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US20150150563A1 (en) * | 2008-05-02 | 2015-06-04 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
US20150105817A1 (en) * | 2008-05-02 | 2015-04-16 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
US9597087B2 (en) | 2008-05-02 | 2017-03-21 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US10610231B2 (en) | 2008-05-02 | 2020-04-07 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
US9179918B2 (en) | 2008-07-22 | 2015-11-10 | Covidien Lp | Vascular remodeling device |
US9095342B2 (en) | 2009-11-09 | 2015-08-04 | Covidien Lp | Braid ball embolic device features |
US9814562B2 (en) | 2009-11-09 | 2017-11-14 | Covidien Lp | Interference-relief type delivery detachment systems |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US9468442B2 (en) | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
US8926681B2 (en) | 2010-01-28 | 2015-01-06 | Covidien Lp | Vascular remodeling device |
US9844382B2 (en) | 2010-09-10 | 2017-12-19 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US10898200B2 (en) | 2010-09-10 | 2021-01-26 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US10675037B2 (en) * | 2010-09-10 | 2020-06-09 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US20180132859A1 (en) * | 2010-09-10 | 2018-05-17 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US20210244420A1 (en) * | 2010-09-10 | 2021-08-12 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
US10617426B2 (en) | 2010-09-10 | 2020-04-14 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US8974512B2 (en) | 2010-09-10 | 2015-03-10 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
US10064627B2 (en) | 2010-09-10 | 2018-09-04 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US11534176B2 (en) | 2010-09-10 | 2022-12-27 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US10939916B2 (en) | 2010-09-10 | 2021-03-09 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US10617427B2 (en) | 2010-09-10 | 2020-04-14 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US9855052B2 (en) | 2010-09-10 | 2018-01-02 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US9855051B2 (en) | 2010-09-10 | 2018-01-02 | Covidien Lp | Devices and methods for the treatment of vascular defects |
US9393022B2 (en) | 2011-02-11 | 2016-07-19 | Covidien Lp | Two-stage deployment aneurysm embolization devices |
US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
US10004511B2 (en) | 2011-03-25 | 2018-06-26 | Covidien Lp | Vascular remodeling device |
US11147563B2 (en) | 2011-03-25 | 2021-10-19 | Covidien Lp | Vascular remodeling device |
US8795313B2 (en) | 2011-09-29 | 2014-08-05 | Covidien Lp | Device detachment systems with indicators |
US8945171B2 (en) | 2011-09-29 | 2015-02-03 | Covidien Lp | Delivery system for implantable devices |
US10828182B2 (en) | 2011-09-29 | 2020-11-10 | Covidien Lp | Vascular remodeling device |
US11654037B2 (en) | 2011-09-29 | 2023-05-23 | Covidien Lp | Vascular remodeling device |
US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
US10335155B2 (en) | 2011-11-30 | 2019-07-02 | Covidien Lp | Positioning and detaching implants |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US11406405B2 (en) | 2012-11-06 | 2022-08-09 | Covidien Lp | Multi-pivot thrombectomy device |
US9924959B2 (en) | 2012-11-06 | 2018-03-27 | Covidien Lp | Multi-pivot thrombectomy device |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
US11786253B2 (en) | 2012-11-13 | 2023-10-17 | Covidien Lp | Occlusive devices |
US11690628B2 (en) | 2012-11-13 | 2023-07-04 | Covidien Lp | Occlusive devices |
US10327781B2 (en) | 2012-11-13 | 2019-06-25 | Covidien Lp | Occlusive devices |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9901472B2 (en) | 2013-01-17 | 2018-02-27 | Covidien Lp | Methods and apparatus for luminal stenting |
US9119948B2 (en) | 2013-02-20 | 2015-09-01 | Covidien Lp | Occlusive implants for hollow anatomical structures, delivery systems, and related methods |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
US10743882B2 (en) | 2013-03-15 | 2020-08-18 | Covidien Lp | Delivery and detachment mechanisms for vascular implants |
CN110169802A (en) * | 2013-03-15 | 2019-08-27 | 柯惠有限合伙公司 | The conveying of Vascular implant and separating mechanism |
US10736758B2 (en) | 2013-03-15 | 2020-08-11 | Covidien | Occlusive device |
US11490896B2 (en) | 2013-03-15 | 2022-11-08 | Covidien Lp | Delivery and detachment mechanisms for vascular implants |
US11389309B2 (en) | 2013-03-15 | 2022-07-19 | Covidien Lp | Occlusive device |
WO2014145012A3 (en) * | 2013-03-15 | 2015-03-26 | Covidien Lp | Delivery and detachment mechanisms for vascular implants |
US10076336B2 (en) * | 2013-03-15 | 2018-09-18 | Covidien Lp | Delivery and detachment mechanisms for vascular implants |
CN105142543A (en) * | 2013-03-15 | 2015-12-09 | 柯惠有限合伙公司 | Delivery and detachment mechanisms for vascular implants |
US20160008003A1 (en) * | 2013-03-15 | 2016-01-14 | Covidien Lp | Delivery and detachment mechanisms for vascular |
US11291452B2 (en) * | 2013-06-26 | 2022-04-05 | W. L. Gore & Associates, Inc. | Medical device deployment system |
US20150005808A1 (en) * | 2013-06-26 | 2015-01-01 | W. L. Gore & Associates, Inc. | Medical device deployment system |
US10939914B2 (en) | 2013-08-16 | 2021-03-09 | Sequent Medical, Inc. | Filamentary devices for the treatment of vascular defects |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11723667B2 (en) | 2013-08-16 | 2023-08-15 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
US10813645B2 (en) | 2013-08-16 | 2020-10-27 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9492174B2 (en) | 2013-08-16 | 2016-11-15 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US10136896B2 (en) | 2013-08-16 | 2018-11-27 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11678886B2 (en) | 2014-04-14 | 2023-06-20 | Microvention, Inc. | Devices for therapeutic vascular procedures |
US11284901B2 (en) | 2014-04-30 | 2022-03-29 | Cerus Endovascular Limited | Occlusion device |
US11389174B2 (en) | 2014-04-30 | 2022-07-19 | Cerus Endovascular Limited | Occlusion device |
US11871931B2 (en) | 2014-08-08 | 2024-01-16 | DePuy Synthes Products, Inc. | Embolic coil delivery system with retractable mechanical release mechanism |
US11883032B2 (en) | 2015-02-25 | 2024-01-30 | Galaxy Therapeutics, Inc. | System for and method of treating aneurysms |
US10856879B2 (en) | 2015-02-25 | 2020-12-08 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
US9375333B1 (en) | 2015-03-06 | 2016-06-28 | Covidien Lp | Implantable device detachment systems and associated devices and methods |
US11357510B2 (en) | 2015-09-23 | 2022-06-14 | Covidien Lp | Occlusive devices |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US11471162B2 (en) | 2015-12-07 | 2022-10-18 | Cerus Endovascular Limited | Occlusion device |
US11678888B2 (en) | 2016-02-10 | 2023-06-20 | Microvention, Inc. | Devices for vascular occlusion |
US10980545B2 (en) | 2016-02-10 | 2021-04-20 | Microvention, Inc. | Devices for vascular occlusion |
US20190053810A1 (en) * | 2016-03-11 | 2019-02-21 | Cerus Endovascular Limited | Occlusion device |
US10869672B2 (en) * | 2016-03-11 | 2020-12-22 | Cents Endovascular Limited | Occlusion device |
US11648013B2 (en) | 2016-03-11 | 2023-05-16 | Cerus Endovascular Limited | Occlusion device |
US11376012B2 (en) | 2016-08-04 | 2022-07-05 | Covidien Lp | Devices, systems, and methods for treatment of vascular defects |
US10478195B2 (en) | 2016-08-04 | 2019-11-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11191927B2 (en) | 2017-07-31 | 2021-12-07 | Boston Scientific Scimed, Inc. | Dilator with engagement region |
US11000287B2 (en) | 2017-08-15 | 2021-05-11 | Boston Scientific Scimed, Inc. | Occlusive medical device system |
US11812971B2 (en) | 2017-08-21 | 2023-11-14 | Cerus Endovascular Limited | Occlusion device |
US11304700B2 (en) | 2017-08-22 | 2022-04-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US10675036B2 (en) | 2017-08-22 | 2020-06-09 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US10874402B2 (en) | 2017-10-10 | 2020-12-29 | Boston Scientific Scimed, Inc. | Detachable RF energized occlusive device |
US11832836B2 (en) | 2017-12-11 | 2023-12-05 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11633201B2 (en) | 2017-12-11 | 2023-04-25 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11826051B2 (en) | 2017-12-21 | 2023-11-28 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube and cylindrical coupling |
US11185335B2 (en) | 2018-01-19 | 2021-11-30 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
US11284902B2 (en) | 2018-02-01 | 2022-03-29 | Boston Scientific Scimed, Inc. | Method of making a vascular occlusion device |
US11154412B2 (en) | 2018-02-01 | 2021-10-26 | Boston Scientific Scimed, Inc. | Medical device release system |
US11666350B2 (en) | 2018-06-22 | 2023-06-06 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11147562B2 (en) | 2018-12-12 | 2021-10-19 | DePuy Synthes Products, Inc. | Systems and methods for embolic implant detachment |
US11278291B2 (en) | 2018-12-17 | 2022-03-22 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11730485B2 (en) | 2018-12-17 | 2023-08-22 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11678887B2 (en) | 2018-12-17 | 2023-06-20 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11324513B2 (en) | 2018-12-17 | 2022-05-10 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11129621B2 (en) | 2018-12-17 | 2021-09-28 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11559309B2 (en) | 2019-03-15 | 2023-01-24 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11317921B2 (en) | 2019-03-15 | 2022-05-03 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US11291453B2 (en) | 2019-03-15 | 2022-04-05 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
US11612430B2 (en) | 2019-03-19 | 2023-03-28 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11622771B2 (en) | 2019-05-25 | 2023-04-11 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11166731B2 (en) | 2019-05-25 | 2021-11-09 | Galaxy Therapeutics Inc. | Systems and methods for treating aneurysms |
US11202636B2 (en) | 2019-05-25 | 2021-12-21 | Galaxy Therapeutics Inc. | Systems and methods for treating aneurysms |
US11058431B2 (en) * | 2019-05-25 | 2021-07-13 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11033277B2 (en) | 2019-05-25 | 2021-06-15 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US10856880B1 (en) | 2019-05-25 | 2020-12-08 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11191558B2 (en) | 2019-06-12 | 2021-12-07 | Covidien Lp | Retrieval of material from corporeal lumens |
US11523838B2 (en) * | 2019-06-12 | 2022-12-13 | Covidien Lp | Retrieval of material from corporeal lumens |
US11253265B2 (en) | 2019-06-18 | 2022-02-22 | DePuy Synthes Products, Inc. | Pull wire detachment for intravascular devices |
US11207494B2 (en) | 2019-07-03 | 2021-12-28 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11672946B2 (en) | 2019-09-24 | 2023-06-13 | Boston Scientific Scimed, Inc. | Protection and actuation mechanism for controlled release of implantable embolic devices |
US11426174B2 (en) | 2019-10-03 | 2022-08-30 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant mechanical release |
US11633818B2 (en) | 2019-11-04 | 2023-04-25 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11685007B2 (en) | 2019-11-04 | 2023-06-27 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11717924B2 (en) | 2019-11-04 | 2023-08-08 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11679458B2 (en) | 2019-11-04 | 2023-06-20 | Covidien Lp | Devices, systems, and methods for treating aneurysms |
US11376013B2 (en) | 2019-11-18 | 2022-07-05 | DePuy Synthes Products, Inc. | Implant delivery system with braid cup formation |
US11395668B2 (en) | 2019-12-12 | 2022-07-26 | Covidien Lp | Electrically enhanced retrieval of material from vessel lumens |
US11457922B2 (en) | 2020-01-22 | 2022-10-04 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11432822B2 (en) * | 2020-02-14 | 2022-09-06 | DePuy Synthes Products, Inc. | Intravascular implant deployment system |
US20210251635A1 (en) * | 2020-02-14 | 2021-08-19 | DePuy Synthes Products, Inc. | Intravascular implant deployment system |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
US11931041B2 (en) | 2021-05-10 | 2024-03-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11844490B2 (en) | 2021-12-30 | 2023-12-19 | DePuy Synthes Products, Inc. | Suture linkage for inhibiting premature embolic implant deployment |
Also Published As
Publication number | Publication date |
---|---|
JP5711251B2 (en) | 2015-04-30 |
EP2498691B1 (en) | 2015-01-07 |
AU2010314871B2 (en) | 2014-10-30 |
WO2011057277A3 (en) | 2011-07-28 |
CA2779483A1 (en) | 2011-05-12 |
CN102791205A (en) | 2012-11-21 |
AU2010314871A1 (en) | 2012-05-31 |
CA2779483C (en) | 2018-03-13 |
ES2534192T3 (en) | 2015-04-20 |
EP2498691A2 (en) | 2012-09-19 |
US20110319926A1 (en) | 2011-12-29 |
JP2013509972A (en) | 2013-03-21 |
US9095342B2 (en) | 2015-08-04 |
WO2011057277A2 (en) | 2011-05-12 |
CN102791205B (en) | 2016-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9095342B2 (en) | Braid ball embolic device features | |
US9814562B2 (en) | Interference-relief type delivery detachment systems | |
US20220022886A1 (en) | Multiple layer filamentary devices for treatment of vascular defects | |
WO2014152579A1 (en) | Interference-relief type delivery detachment systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UT-BATTELLE, LLC, TENNESSEE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:IVANOV, ILIA N.;SIMPSON, JOHN T.;SIGNING DATES FROM 20101202 TO 20101208;REEL/FRAME:025480/0387 |
|
AS | Assignment |
Owner name: NFOCUS NEUROMEDICAL, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOGANATHAN, SIDDHARTH;BECKING, FRANK P.;DEBEER, NICHOLAS C.;REEL/FRAME:026184/0516 Effective date: 20110426 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: NFOCUS LLC, CALIFORNIA Free format text: MERGER;ASSIGNOR:NFOCUS NEUROMEDICAL, INC.;REEL/FRAME:030944/0799 Effective date: 20130330 Owner name: COVIDIEN LP, MASSACHUSETTS Free format text: MERGER;ASSIGNOR:NFOCUS LLC;REEL/FRAME:030944/0839 Effective date: 20130330 |